<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.01" name="make smaller&#x0A;" wordnet="2">
                <roles>
                    <role n="0" descr="agent&#x0A;" />
                    <role n="1" descr="thing decrease&#x0A;" />
                    <role n="2" descr="location&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A 0 (loco marA) was decrease a reduction in porin expression OmpF in mutants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excess of ArcA may have significantly decreased the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Clara cell secretor protein levels were shown to be decreased in smokers NLF, and it has also been found that the NLF of smokers contained increased ratios of a truncated variant of lipocortin-1, three acidic alpha forms (1)-antitrypsin, and a phosphorylated form of cyttin S.Syntrophin binds to an exon spalmate of dystrophin.</text>
                </example>
                <example src="EGRAM" no="3">
                    <text>Clench cell secretory protein levels can be decreased in NLF of smokers, and it was also found that NLF of smokers contained increased proportions of a truncated lipocortin-1 variant, three acid forms of alpha (1)-antitrypsin and a phosphorylated form of cystatin S.Syntrophin binds to an exon of dystrophin in</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Clench cell secretory protein levels is able to be decreased in the NLF of smokers, and it was also found that the NLF of smokers contained increased proportions of a truncated lipocortin-1 variant, three acid forms of alpha (1)-antitrypsin and a phosphorylated form of cystatin S.Syntrophin binds to an exon of</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Clench cell secretory protein levels is able to decreased the NLF of smokers, and it was also found that the NLF of smokers contained increased proportions of a truncated lipocortin-1 variant, three acid forms of alpha (1)-antitrypsin and a phosphorylated form of cystatin S.Syntrophin binds to an exon of dys</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Clench cell secretory protein levels may have been decreased in the NLF of smokers, and it was also found that the NLF of smokers contained increased proportions of a truncated lipocortin-1 variant, three acid forms of alpha (1)-antitrypsin and a phosphorylated form of cystatin S.Syntrophin binds to an alternative pul</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Clench cell secretory protein levels was decreased in NLF of smokers, and it was also found that NLF of smokers contained increased proportions of a truncated lipocortin-1 variant, three acid forms of alpha (1)-antitrypsin and a phosphorylated form of cystatin S.Syntrophin binds to an exon of dystrophin in</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and excessive arcA expression has been shown to significantly decrease glucose intake.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>If this 30-amino acid distance is not maintained, such as in the human AspRS chimera#1, or in the LysTS chimera of yeast#1 and in the AsnRS chimera of yeast#2 (Figure 5B), the tRNA binding is strongly affected and protection will be decreased or even abolished in the case of the human AspRS chimera#1 (Table).</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>If this 30-amino acid distance is not maintained, such as in the human AspRS chimera#1, or in the LysTS chimera of yeasts#1 and in the AsnRS chimera of yeasts#2 (Figure 5B), the tRNA binding is strongly affected and protection is believed to be decreased or even abolished in the case of the human AspRS chimera#1 (</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>If this distance of 30 amino acids is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA is strongly affected and protection has been decreased, or even abolished in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>If this distance of 30 amino acids is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA was strongly affected and protection was decreased, or even abolished in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>If this distance of 30 amino acids is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA will be severely affected and protection will have been decreased, or even abolished in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, the contents of MRNA may have decreased significantly (4050%; see Table 2).</text>
                </example>
                <example src="EGRAM" no="15">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, RELN mRNA content was able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">RELN mRNA content</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consisting of these expression levels can be reduced and the methionine content can be decreased), and neither RAP2 nor RAP3 are coimmunoprecipites in RAP1 mutants.</text>
                </example>
                <example src="EGRAM" no="17">
                    <text>In contrast, only low levels of truncated RAP1 peptides were decreased (consisting of this expression, A1 levels (methionine content) were lower and there was no coimmunoprecipitation of RAP2 and RAP3 in RAP1 mutants.</text>
                </example>
                <example src="EGRAM" no="18">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were decreased (consistent with this expression, A1 levels (methionine content) were lower and there was no co-immunoprecipitation of RAP2 and RAP3 in RAP1 mutants.</text>
                </example>
                <example src="EGRAM" no="19">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consistent with this expression it was possible to decreased and methionine content was able to decreased, and neither RAP2 nor RAP3 was co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">methionine content</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consistent with this expression, the levels may be decreased and methionine content may be decreased), and neither RAP2 nor RAP3 were co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">methionine content</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>In schizophrenia patients who are homologous to non-psychiatric mRNAs, the content of RELN mRNA is decreasing significantly (4050%; see Table 2).</text>
                </example>
                <example src="EGRAM" no="22">
                    <text>In schizophrenia patients who are homologous to those of non-psychiatric subjects, the contents of RNA mRNA would be significantly decreased (4050%; see Table 2).</text>
                </example>
                <example src="EGRAM" no="23">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric individuals, it is demonstrated that MRNA RELN content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">MRNA RELN content</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, mRNA reLN content will be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>In the cerebral areas of schizophrenia patients homologous to non-psychiatric subjects, the contents of MRNA RELN is significantly decreasing (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA RELN</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it is shown that the contents of MRNA RELN is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA RELN</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the contents of MRNA reLN is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA reLN</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>It was believed that narL drive decreases nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>It was shown that the narL drive decreases the nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Loco de MarA has been shown to decrease the expression of opmF porin expression in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>Loco de MarA may decrease the expression of opmF porin expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>Loco de MarA was able to decrease the expression of opmpF porin expression in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation had the ability to decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation may decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and six mutations has been considered to decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation can decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoting activity can be decreased by mutation in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotive activity has decreased by mutation in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoter activity would be decreased by mutation to cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea) (multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>The NirB promoter nitrite induction was decreased in the narc removal, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>The clean cell secretor protein levels will be decreased in the NLF of smokers, and the NLF of smokers has also been found to contain increased ratios of a truncated variant of lipocortin-1, three acidic alpha forms (1)-antitrypsin, and a phosphorylated form of the cytotin S.Syntrophin binds to an exon spalmate of dystrophin.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>The clench cell secretor protein levels was decreased in the NLF of smokers, and it was also found that the NLF of smokers contained increased ratios of a truncated variant of lipocortin-1, three alpha acid forms (1)-antitrypsin and a phosphorylated form of cyttin S.Syntrophin binds to an exon of dystrophin</text>
                    <arg n="1">clench cell secretor protein levels</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>The cloth cell secretor protein levels may have been decreased in the NLF of smokers, and the NLF of smokers has also been found to contain increased ratios of a truncated variant of lipocortin-1, three acidic alpha forms (1)-antitrypsin, and a phosphorylated form of cytotin S.Syntrophin binds to an exon spalmate of dystrophin.</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that excessive expression of arcA significantly decreased glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that the expression of ArcAs overexpression significantly decreased the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and A0 is capable of significantly decreasing the consumption of glucose.</text>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression can significantly decrease glucose consumption.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression could significantly decrease the consumption of glucose.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA was able to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that the glucose consumption was significantly decreased for the excessive expression of ArcA significantly.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption can be significantly decreased for the excessive expression of Arca to do so significantly.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that over Arca expression significantly decreases glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and overarch expression would significantly decrease the glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>The nitrite induction of the nirB promoter has been decreased by narL drive which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>The nitrite induction of the nirB promoter was decreased by narcotic removal, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>The nitrite induction of the nirB promoter would be decreased by narcotic removal, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>The nitrite induction of the nirB promoter would be decreased by the narL drive that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>The protein levels secreting crystal cells was considered to be decreased in the NLF of smokers, and it was also found that the NLF of smokers contained increased ratios of a truncated variant of lipocortin-1, three acidic alpha forms (1)-antitrypsin and a phosphorylated form of cytotin S.Syntrophin binds to an alternative pulsus</text>
                    <arg n="1">protein levels secreting crystal cells</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and over expression of ArcA is shown to significantly decreased glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>Treaty with melatonin was able to decrease lipid peroxide synthesis, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>hair peroxide synthesis can be decreased by melatonin treatment, and allows for the recovery of both decreased glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>lipid peroxide synthesis is decreased by Tractally with melatonin, and allows for the recovery of both decreased glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>lipid peroxide synthesis is thought to be decreased by Tractally with melatonin, and allows for the recovery of both decreased glutathione and scavenger enzymatic activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>lipid peroxide synthesis may have been decreased by Tractally with melatonin, and has allowed the recovery of both decreased glutathione and scavenger enzymatic activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>lipid peroxide synthesis was decreased by melatonin treatment, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>lipid peroxide synthesis was decreased to Tractally with melatonin, and allowed both decreased glutathione and scaveners activity to recover.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>lipid peroxide synthesis will be decreased by Tractally with melatonin, and allows for the recovery of both decreased glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>lipid peroxide synthesis would be decreased by Tractally with melatonin, and would allow a recovery of both decreased glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>lipody peroxide synthesis has been shown to be decreased by melatonin treatment, and allowed both decreased glutathione and scavenger activity to recover.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>lipody peroxide synthesis has been shown to be decreased by melatonin treatment, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>loco marA is able to decrease expression of porin OmpF in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>loco marA may have decreased porin expression OmpF in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>melatonin treatment can decrease lipodyl peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>melatonin treatment would decrease lipodyl peroxide synthesis, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>narL discontinuation is able to decrease nirB promoter nitric induction, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>narcophagus interruption may decrease the nitric induction of nitric induction promoter of nirB, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>nitrite induction from the nirB promoter can be decreased by narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>nitrite induction from the nirB promoter can be decreased by narcotic withdrawal, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>nitrite induction of the nirB promoter is capable of being decreased by narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>pore expression in mutants resistant to antibiotics (Mar) of Escherichia coli would be decreased by MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus) (multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus) (multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus) (multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>production of C51 microcins will decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>rupture of narL will decrease nirB promoter nitrite induction, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>the production of C51 microcin could decrease or be absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>the production of C51 microcin has decreased or been absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>the production of C51 microcin is able to decrease or be absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="91">
                    <text>the production of C51 microcin may decrease or be absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="92">
                    <text>the production of C51 microcin was thought to decrease or be absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="93">
                    <text>the production of C51 microcin will decrease or be absent in rpoS, crp, and cya mutant cells.</text>
                    <arg n="1">the production of C51 microcin</arg>
                    <arg n="2">rpoS, crp, and cya mutant cells</arg>
                </example>
                <example src="EGRAM" no="94">
                    <text>treatment with melatonin can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A0 has decreased nirB promoter, and has enabled the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="1">nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A0 has the ability to decrease methionine content without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">methionine content</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A0 has the ability to decrease protection without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A0 is able to decrease the nitric induction of production of C51 microcins, without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Loco de Abraça is thought to have significantly decreased OmpF porin.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Loco de MarA can significantly decrease OmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Loco de MarA can significantly decrease OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Loco de MarA is thought to have significantly decreased OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Loco de MarA is thought to have significantly decreased or OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and MarA site may have significantly decreased OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Melatonin treatment is thought to have significantly decreased lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Treaty with melatonin is thought to have significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and Treaty with melatonin may have significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excess ArcA can significantly decrease glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excessive ArcA expression can significantly decrease glucose intake.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excessive ArcA expression is thought to have significantly decreased glucose intake.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excessive Ark expression is thought to have significantly decreased glucose intake.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and excessive expression of arcA may have significantly decreased glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and loco marA can significantly decrease perhaps OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and loco marA can significantly decrease porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and loco marA is thought to have significantly decreased OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and loco marA is thought to have significantly decreased expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and loco marA is thought to have significantly decreased perhaps OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and melatonin treatment can significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and nail blackout is thought to have significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narL drive can significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narL drive may have significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narL withdrawal can significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narL withdrawal is thought to have significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narc removal is thought to have significantly decreased NirB promoter nitrite induction.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narcophagus interruption can significantly decrease nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narcotic induction can significantly decrease NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narcotic removal may have significantly decreased nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and narthida withdrawal is thought to have significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and natron activation may have significantly decreased nitrogen nitrite induction of nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and over Arca expression can significantly decrease glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and over expression of ArcA may have significantly decreased glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and overarch expression is thought to have significantly decreased glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and overexpression of ArcA may have significantly decreased glucose intake.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and rupture of narL can significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>C51 microcin production could decrease or be absent in rpoS, crp and cyanol mutant cells.</text>
                    <arg n="1">C51 microcin production</arg>
                    <arg n="2">rpoS, crp and cyanol mutant cells</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>C51 microcin production is able to decrease or be absent in rpoS, crp and cyanol mutant cells.</text>
                    <arg n="1">C51 microcin production</arg>
                    <arg n="2">rpoS, crp and cyanol mutant cells</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>C51 microcin production was able to decrease or be absent in rpoS, crp and cyanol mutant cells.</text>
                    <arg n="1">C51 microcin production</arg>
                    <arg n="2">rpoS, crp and cyanol mutant cells</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>C51 microcin production would decrease or be absent in the mutant cells rpoS, crp and cyanol mutant cells.</text>
                    <arg n="1">C51 microcin production</arg>
                    <arg n="2">rpoS, crp and cyanol mutant cells</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Druption of narL could decrease nitrite induction of the nirB promoter, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Druption of narL decreased nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Druption of narL decreases nitrite induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Druption of narL decreases the expression of digit induction of the nirB promoter in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Druption of narL has been shown to decrease digit induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Druption of narL has decreased nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Druption of narL is able to decrease digit induction of the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Druption of narL is able to decrease nitrite induction of the nirB promoter, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Druption of narL is able to decrease nitrite induction of the nirB promoter, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Druption of narL is able to decrease the nitrite induction of the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Druption of narL is thought to decrease nitrite induction of the nirB promoter and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Druption of narL is thought to decrease the expression of digit induction of the nirB promoter in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Druption of narL may decrease nitrite induction of the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Druption of narL was able to decrease nitrite induction of the nirB promoter, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Druption of narL was able to decrease the nitrite induction of the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Druption of narL was shown to decrease the digit induction of the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Druption of narL will decrease digit induction of the nirB promoter and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Druption of narL will decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Druption of narL would decrease nitrite induction nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Druption of narL would decrease nitrite induction of the nirB promoter, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that Druption of narL significantly decreased digit induction of the nirB promoter.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that Loco de MarA significantly decreased OmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that Loco de MarA significantly decreased opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that Loco de MarA significantly decreased or OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that arcA expression significantly decreased glucose consumption.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that excess ArcA significantly decreased glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that excessive ArcA significantly decreased the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that excessive arc expression significantly decreased glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that excessive expression ArcA significantly decreased glucose intake.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that loco marA significantly decreased or OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that narL discontinuation significantly decreased nirB promoter nitric induction.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that narcophagus interruption significantly decreased nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that over Arca expression significantly decreased glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that the excessive expression of Arca significantly decreased the glucose consumption.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and A0 is able to significantly decrease lipid peroxide synthesis.</text>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and A0 is able to significantly decrease nitric induction promoter of nirB.</text>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and Loco de MarA has been shown to significantly decrease opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and arcA expression has been shown to significantly decrease the consumption of glucose.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and excessive expression of arcA has been shown to significantly decrease glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that OmpF porin was significantly decreased to Loco de Abraça.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that glucose intake was significantly decreased to excessive Ark expression.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that glucose intake was significantly decreased to excessive arcA expression.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that glucose intake was significantly decreased to exposing excessive arcA.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that glucose intake was significantly decreased to over Arca expression.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that lipody peroxide synthesis was significantly decreased to melatonin treatment.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that nirB promoter nitrite induction was significantly decreased to rupture of narL.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that porin expression OmpF was significantly decreased to loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that the consumption of glucose was significantly decreased to arcA expression.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and narL-disruption has been shown to significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and narcotic removal has been shown to significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and natron activation has been shown to significantly decrease nitrite induction of nickel nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and over expression of ArcA has been shown to significantly decrease glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and overexpression of ArcA has been shown to significantly decrease glucose intake.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli can be decreased by marA place.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli has decreased to mara place.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli is shown to be decreased by mara place.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli may have been decreased in marA place.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli was decreased in mara place.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, RELN mRNA content is able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">RELN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, melatonin treatment was able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">melatonin treatment</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, perhaps NarL is able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">perhaps NarL</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, treatment with melatonin is able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the contents of MRNA reLN is able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA reLN</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, treatment with melatonin is able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, treatment with melatonin may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>In brain decreasingas of patients with schizophrenia that decreasing homologous to those of non-psychiatric subjects, RELN mRNA content was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">RELN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>In brain decreasingas of patients with schizophrenia that decreasing homologous to those of non-psychiatric subjects, the contents of MRNA was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>In brain decreasingas of patients with schizophrenia that decreasing homologous to those of non-psychiatric subjects, the reLN mRNA content was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>In brain decreasingas of patients with schizophrenia who decreasing homologous to those of non-psychiatric subjects, narcophagus interruption was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression level may have been reduced and nirB promoter may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression level may have been reduced and nitric induction promoter of nirB may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression level may have been reduced and nitric induction promoter of the nirB may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">nitric induction promoter of the nirB</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and teor methionine may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">teor methionine</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and production of C51 microcins could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these levels of expression could be reduced and production of C51 microcins could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression is able to be lowered and glucose intake is able to be decreased), and neither RAP2 nor RAP3 is co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and lipid peroxide synthesis may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and nitric induction promoter of the nirB may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">nitric induction promoter of the nirB</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and production of C51 microcins may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and protection may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">protection</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and lipid peroxide synthesis could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and nirB promoter could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and production of C51 microcins could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and teor methionine could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">teor methionine</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric individuals, it is demonstrated that the contents of MRNA is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric subjects, narcophagus interruption is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric subjects, the reLN mRNA content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, melatonin treatment is decreased a significant reduction (4050%; see Table 2).</text>
                    <arg n="0">melatonin treatment</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, nirB-promoter nitrite induction would have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">nirB-promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the contents of MRNA reLN is decreased a significant reduction (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA reLN</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, treatment with melatonin is decreased a significant reduction (4050%; see Table 2).</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>In the cerebral areas of patients of schizophrenia homologous to non-psychiatric subjects, nirB-promoter nitrite induction can decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">nirB-promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>In the cerebral areas of schizophrenia patients homologous to non-psychiatric subjects, narcophagus interruption is significantly decreasing (4050%; see Table 2).</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, RELN mRNA content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">RELN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, RNAM content has decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">RNAM content</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, RNLN mRNA content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">RNLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it is shown that RNLN mRNA content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">RNLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it is shown that the reLN mRNA content is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it was shown that MRNA RELN content was significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">MRNA RELN content</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, mRNA reLN content may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, mRNA reLN content was believed to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, melatonin treatment is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">melatonin treatment</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, melatonin treatment may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">melatonin treatment</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, narcophagus interruption may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, nirB-promoter nitrite induction is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">nirB-promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, nirB-promoter nitrite induction would be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">nirB-promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the contents of MRNA RELN would be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA RELN</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the contents of MRNA reLN can be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA reLN</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the contents of MRNA will have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the contents of MRNA</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the reLN mRNA content is thought to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, treatment with melatonin will have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">treatment with melatonin</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>It is believed that excessive Ark expression decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>It is believed that excessive expression ArcA decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>It is believed that loco marA decreases porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>It is believed that melatonin treatment decreases hair peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>It is believed that narL drive decreases nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>It is believed that narL drive decreases nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>It is believed that narcotic removal decreases nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>It is believed that over expression of ArcA decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>It was believed that excess ArcA decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>It was believed that loco marA decreases OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>It was believed that loco marA decreases or OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>It was believed that melatonin treatment decreases lipid peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>It was believed that narL drive decreases NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>It was believed that narL drive decreases nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>It was believed that narL-disruption decreases nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>It was believed that narc removal decreases NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>It was believed that narcophagus interruption decreases nitric induction promoter of nirB without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>It was believed that overarch expression decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>It was believed that rupture of narL decreases nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>It was believed that the OmpF porin expression was decreased by Loco de MarA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>It was believed that the glucose consumption was decreased by arcA expression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>It was believed that the glucose intake was decreased by exposing excessive arcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>It was believed that the glucose intake was decreased by overexpression of ArcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>It was believed that the lipid peroxide synthesis was decreased by Tractally with melatonin that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>It was believed that the lipodyl peroxide synthesis was decreased by Melatonin treatment that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>It was believed that the nirB promoter nitrite induction was decreased by narL drive that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>It was believed that the nitric nirB promoter induction was decreased by narcophagus interruption that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>It was believed that the or OmpF porin expression was decreased by loco marA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>It was believed that the porin expression OmpF was decreased by loco marA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>It was believed that the porin expression OmpF was decreased by locus marA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>It was believed that the the consumption of glucose was decreased by excessive ArcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>It was believed that whether its mutation decreases promoter activity without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>It was shown that the loco marA decreases the porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>It was shown that the locus marA decreases the porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>It was shown that the melatonin treatment decreases the hair peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>It was shown that the narL discontinuation decreases the nirB promoter nitric induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>It was shown that the narc removal decreases the NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>It was shown that the narcophagus interruption decreases the nitric nirB promoter induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>It was shown that the narthida withdrawal decreases the nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>Local MEF2 binding sites have been reported in several cardiac promoters and MarA locus decreases the OmpF porin expression in Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Local MEF2 binding sites have been reported in several cardiac promoters and mutation decreases the promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and MarA locus would decrease OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and MarA locus would decrease pore expression in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and loco marA would decrease Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and mara place would decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and mutation would decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and MarA locus decreases OmpF porin expression in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and MarA locus decreases pore expression in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and MarA locus would decrease OmpF porin expression in Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and its mutation decreases promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and its mutation would decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and loco marA would decrease porin OmpF expression in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and marA place would decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mara place decreases OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mara place would decrease OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mutation decreases promoting activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mutation decreases promoting activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mutation decreases promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mutation would decrease promoting activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and mutation would decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Loco de Abraça decreased the OmpF porin in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Loco de Abraça has the ability to decrease OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Loco de Abraça is thought to decrease OmpF porin, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Loco de Abraça may decrease the expression of OmpF porin in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Loco de Abraça may have decreased OmpF porin in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Loco de Abraça was able to decrease OmpF porin, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Loco de Abraça was able to decrease the OmpF porin in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Loco de Abraça would have decreased the OmpF porin in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Loco de MarA can decrease opmpF porin expression, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Loco de MarA could decrease OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Loco de MarA could decrease OmpF porin without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Loco de MarA could decrease opmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Loco de MarA could decrease or OmpF porin without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Loco de MarA could decrease or OmpF porin, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Loco de MarA decreased opmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Loco de MarA decreased or OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Loco de MarA decreases OmpF porin, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Loco de MarA decreases the opmpF porin expression and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Loco de MarA has been shown to decrease opmpF porin expression, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Loco de MarA has been shown to decrease the expression of opmpF porin expression in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Loco de MarA is able to decrease OmpF porin expression, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Loco de MarA is able to decrease opmF porin expression, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Loco de MarA is able to decrease opmF porin expression, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Loco de MarA is able to decrease or OmpF porin, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Loco de MarA is believed to decrease OmpF porin expression in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>Loco de MarA is shown to decrease OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>Loco de MarA is shown to decrease opmpF porin expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>Loco de MarA is thought to decrease OmpF porin and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>Loco de MarA is thought to decrease opmF porin expression, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>Loco de MarA is thought to decrease the expression of or OmpF porin in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>Loco de MarA may decrease opmpF porin expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>Loco de MarA may decrease or OmpF porin in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>Loco de MarA may decrease the expression of opmF porin expression in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>Loco de MarA may decrease the expression of or OmpF porin in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>Loco de MarA may decrease the nitric induction of opmF porin expression, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>Loco de MarA may have decreased OmpF porin in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>Loco de MarA was able to decrease OmpF porin expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>Loco de MarA was able to decrease the OmpF porin expression in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>Loco de MarA was able to decrease the opmpF porin expression in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>Loco de MarA was thought to decrease opmF porin expression, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>Loco de MarA was thought to decrease or OmpF porin, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>Loco de MarA will decrease OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>Loco de MarA would decrease OmpF porin, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>Loco de MarA would decrease nitrite induction OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>Loco de MarA would decrease nitrite induction opmF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>Loco de MarA would decrease opmpF porin expression, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and Expressive porin expression OmpF can be decreased in marA place in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and MarA locus has been considered to decrease OmpF porin expression in Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and MarA locus has been considered to decrease OmpF porin expression in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and MarA locus may decrease pore expression in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and MarA locus will decrease OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and MarA locus will decrease pore expression in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and OmpF porin expression was decreased in MarA locus in Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and OmpF porin expression was decreased in MarA locus in multi-antibiotic resistant (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and OmpF porin expression was decreased in mara place in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and Purina OmpF expression has been considered to be decreased by loco marA in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and amara place will decrease expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and expression of porin OmpF can be decreased in loco marA in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation had the ability to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation has been considered to decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation has been considered to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation is able to decrease promoting activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and its mutation will decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA decreased OmpF porin expression in multi-antibiotic resistant (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA decreased expression of porin OmpF in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA had the ability to decrease porin OmpF expression in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA has the ability to decrease or OmpF porin expression in resisting with multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA has the ability to decrease porin OmpF expression in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA is able to decrease Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA will decrease Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA will decrease expression of porin OmpF in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and loco marA will decrease or OmpF porin expression in resisting with multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA place has been able to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA place has the ability to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mara place has been able to decrease OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mara place may decrease OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation decreased promoter activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation had the ability to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation had the ability to decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation had the ability to decrease promotive activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation has been able to decrease promotive activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation has been able to decrease promotive activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation may decrease promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation may decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation may decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation may decrease promotive activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation will decrease promoting activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and mutation will decrease promotion activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and pore expression can be decreased in MarA locus in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and pore expression has been considered to be decreased by MarA locus in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and pore expression has been considered to be decreased by MarA locus in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and pore expression was decreased in MarA locus in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and porin OmpF expression has been considered to be decreased by loco marA in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and porin OmpF expression was decreased in loco marA in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promoter activity has been considered to be decreased by its mutation in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promoter activity has been considered to be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promoter activity has been considered to be decreased by six mutations in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased in mutation in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased in mutation in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased in mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased in six mutations in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotive activity has been considered to be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotive activity was decreased in mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and promotive activity was decreased in their mutation in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and six mutations had the ability to decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and six mutations had the ability to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and six mutations has been able to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and their mutation has been considered to decrease promotive activity in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and Expressive porin expression OmpF is believed to be decreased in mara place into multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and OmpF porin expression is able to be decreased in Mar location into Mar.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and OmpF porin expression is believed to be decreased in MarA locus into Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and Purina OmpF expression has been considered to be decreased by loco marA in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and expression of porin OmpF is able to be decreased in loco marA into multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and expressive expression of OmpF pores is able to be decreased in mar place into multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and expressive expression of OmpF pores is believed to be decreased in mar place into multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and pore expression has been considered to be decreased by MarA locus in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and pore expression is able to be decreased in MarA locus into multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is believed to be decreased in loco marA into multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promoting activity has been considered to be decreased by mutation in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promotion activity has been considered to be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promotion activity is able to be decreased in its mutation into cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promotion activity is able to be decreased in mutation into cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promotion activity is believed to be decreased in mutation into cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and promotive activity is believed to be decreased in mutation into cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>MarA locus can decrease OmpF pore expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>MarA locus could decrease OmpF pore expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>MarA locus decreased OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>MarA locus decreased OmpF porin expression in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>MarA locus decreased the OmpF pore expression in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>MarA locus decreased the expression of or OmpF porin expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>MarA locus has the ability to decrease or OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>MarA locus has the ability to decrease the OmpF porin expression to multi-antibiotic resistant (Mar) mutants of Eschrichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>MarA locus is able to decrease OmpF pore expression, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>MarA locus is thought to decrease OmpF pore expression, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>MarA locus may decrease pore expression in mutants of Escherichia coli multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>MarA locus may have decreased or OmpF porin expression in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>MarA locus may have decreased or OmpF porin expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>MarA locus was able to decrease OmpF pore expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>MarA locus was able to decrease OmpF pore expression, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>MarA locus will decrease OmpF porin expression in mutants of Escherichia coli Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>MarA locus will decrease the OmpF porin expression in mutants of Escherichia coli multi-antibiotic resistant (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>MarA locus would decrease the OmpF porin expression in mutants of Escherichia coli Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>MarA locus would decrease the pore expression in mutants of Escherichia coli multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>MarA site can decrease OmpF porin expression, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>MarA site can decrease OmpF porin, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>MarA site could decrease OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>MarA site could decrease OmpF porin, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>MarA site decreases the OmpF porin and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>MarA site is able to decrease OmpF porin expression, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>MarA site is able to decrease OmpF porin expression, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>MarA site is shown to decrease OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>MarA site is shown to decrease OmpF porin, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>MarA site may decrease the expression of OmpF porin in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>MarA site will decrease OmpF porin expression and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>MarA site will decrease OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and Loco de MarA is supposed to decrease opmF porin expression (cardiomyocytes).</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and Loco de MarA is supposed to decrease opmpF porin expression (cardiomyocytes).</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and Loco de MarA is supposed to decrease or OmpF porin (cardiomyocytes).</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and MarA locus can decrease OmpF porin expression in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and MarA locus had the ability to decrease OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and MarA locus is supposed to decrease OmpF pore expression (cardiomyocytes).</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and MarA locus is supposed to decrease or OmpF porin expression (cardiomyocytes).</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and MarA locus will decrease OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and OmpF porin expression can be decreased by mara place in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and OmpF porin expression could be decreased by loco marA in multi-antibiotic resistant (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and OmpF porin expression could be decreased by mara place in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and OmpF porin expression is thought to be decreased by Mar location in Mar.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and amara place is thought to decrease expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and excess of ArcA expression is supposed to decrease the consumption of glucose (cardiomyocytes).</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and excessive ArcA expression is supposed to decrease glucose intake (cardiomyocytes).</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and excessive ArcA is supposed to decrease the consumption of glucose (cardiomyocytes).</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and expression of porin OmpF can be decreased by loco marA in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and expressive expression of OmpF pores can be decreased by mar place in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and expressive expression of OmpF pores has decreased by mar place in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and expressive expression of OmpF pores was able to be decreased by mar place in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and its mutation can decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and its mutation is thought to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and loco marA can decrease Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and loco marA is supposed to decrease expression of porin OmpF (cardiomyocytes).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and loco marA is supposed to decrease opmpF porin expression (cardiomyocytes).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and loco marA is thought to decrease expression of porin OmpF in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and loco marA will decrease expression of porin OmpF in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mar place is thought to decrease expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA place is able to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA place is thought to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA place will decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mara place had the ability to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mara place is thought to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and melatonin treatment is supposed to decrease lipody peroxide synthesis (cardiomyocytes).</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation can decrease promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation can decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation can decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation had the ability to decrease promotion activity in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation is able to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and mutation is thought to decrease promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and narL drive is supposed to decrease NirB promoter nitrite induction (cardiomyocytes).</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and narcophagus interruption is supposed to decrease nitric nirB promoter induction (cardiomyocytes).</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and narcotic removal is supposed to decrease nitrite induction of the nirB promoter (cardiomyocytes).</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and or OmpF porin expression was able to be decreased by loco marA in resisting with multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and over expression of ArcA is supposed to decrease glucose intake (cardiomyocytes).</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and overexpression of ArcA is supposed to decrease glucose intake (cardiomyocytes).</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and pore expression has decreased by MarA locus in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and pore expression has decreased by MarA locus in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and pore expression is decreased by MarA locus in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and pore expression is thought to be decreased by MarA locus in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and pore expression was able to be decreased by MarA locus in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoter activity can be decreased by its mutation in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoter activity could be decreased by mutation in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoter activity could be decreased by six mutations in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoter activity is thought to be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoter activity will be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoting activity can be decreased by mutation in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promoting activity will be decreased by its mutation in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased by its mutation in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity can be decreased by mutation in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity has decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity is decreased by mutation in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity is decreased by mutation in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotion activity was able to be decreased by its mutation in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotive activity can be decreased by mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotive activity can be decreased by their mutation in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and promotive activity could be decreased by mutation in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and six mutations had the ability to decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and six mutations is able to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>MeF2 binding sites have been reported in several cardiac promoters, and loco marA has the ability to decrease expression of porin OmpF in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>MeF2 binding sites have been reported in several cardiac promoters, and loco marA has the ability to decrease or OmpF porin expression in resisting with multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>MeF2 binding sites have been reported in several cardiac promoters, and mutation has the ability to decrease promotion activity in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and Expressive porin expression OmpF would be decreased by marA place to multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and MarA locus may decrease OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and MarA locus may decrease pore expression in mutants resistant to antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">mutants resistant to antibiotics (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression is able to decreased to MarA locus in Many antibiotic resistant mutants (Mar) of Eschherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression is decreased in Mar location in Mar.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression is decreased in MarA locus in multi-antibiotic resistant (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression was able to be decreased by Mar location into Mar.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression would be decreased by Mar location to Mar.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression would be decreased by MarA locus to multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and OmpF porin expression would be decreased by loco marA to multi-antibiotic resistant (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expression of porin OmpF has been decreased by loco marA to resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expression of porin OmpF is decreased in loco marA in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expression of porin OmpF may be decreased by loco marA to multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expression of porin OmpF would be decreased in loco marA in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expressive expression of OmpF pores is able to decreased to mar place in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expressive expression of OmpF pores will be decreased by amara place to multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and expressive expression of OmpF pores would be decreased in amara place in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and loco marA has been considered to decrease OmpF porin expression in multi-antibiotic resistant (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and loco marA has been considered to decrease Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and loco marA may decrease porin OmpF expression in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and mara place has been considered to decrease Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and mara place has been considered to decrease OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and mutation may decrease promoter activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and mutation may decrease promoter activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and mutation may decrease promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression may be decreased by loco marA to multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoter activity is able to decreased to its mutation in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoter activity may be decreased by mutation to cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoter activity would be decreased in mutation in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoter activity would be decreased in six mutations in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity has been decreased by mutation to cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity was able to be decreased by its mutation into cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity was able to be decreased by mutation into cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity would be decreased by its mutation to cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity would be decreased by mutation to coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promoting activity would be decreased in mutation in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity has been decreased by its mutation to cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity has been decreased by mutation to cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity is able to decreased to its mutation in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity is able to decreased to mutation in cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity is able to decreased to six mutations in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity may be decreased by mutation to cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity was able to be decreased by its mutation into cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity was able to be decreased by mutation into cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity will be decreased by six mutations to cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity would be decreased in its mutation in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity would be decreased in mutation in cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotion activity would be decreased in six mutations in cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotive activity is able to decreased to mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotive activity is able to decreased to their mutation in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotive activity is decreased in mutation in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotive activity may be decreased by mutation to cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and promotive activity would be decreased in mutation in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and their mutation may decrease promotive activity in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>Melatonin treatment could decrease nitric induction lipodyl peroxide synthesis while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>Melatonin treatment decreases the lipodyl peroxide synthesis and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>Melatonin treatment has been shown to decrease the expression of lipodyl peroxide synthesis in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>Melatonin treatment is able to decrease the lipodyl peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>Melatonin treatment may decrease the expression of lipodyl peroxide synthesis in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>Melatonin treatment may decrease the nitric induction of lipodyl peroxide synthesis, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>Melatonin treatment may have decreased lipodyl peroxide synthesis, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>Melatonin treatment was able to decrease the lipodyl peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>Melatonin treatment was thought to decrease lipodyl peroxide synthesis, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>Melatonin treatment will decreased lipodyl peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>NirB promoter nitrite induction has been shown to be decreased by narc removal, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>NirB promoter nitrite induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by narc removal.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>NirB promoter nitrite induction is able to be decreased by narL drive, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>NirB promoter nitrite induction is decreased by narc removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>NirB promoter nitrite induction was considered to be decreased by narL drive, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>NirB promoter nitrite induction was decreased by narL drive, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>NirB propulsion nitrite induction can be decreased by narcotic induction which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>NirB propulsion nitrite induction is capable of being decreased by narcotic induction that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>NirB propulsion nitrite induction is decreased by narcotic induction, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>NirB propulsion nitrite induction was decreased by narcotic induction, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>OmpF pore expression can be decreased by MarA locus, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>OmpF pore expression is capable of being decreased by MarA locus that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>OmpF pore expression is thought to be decreased in MarA locus, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>OmpF porin can be decreased by Loco de Abraça that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>OmpF porin can be decreased by Loco de Abraça, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>OmpF porin can be decreased by Loco de MarA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>OmpF porin expression has been shown to be decreased by MarA site, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>OmpF porin expression has been shown to be decreased by MarA site, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>OmpF porin expression has decreased by loco marA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>OmpF porin expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>OmpF porin expression in Many antibiotic resistant mutants (Mar) of Eschherichia coli has decreased to MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Many antibiotic resistant mutants (Mar) of Eschherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>OmpF porin expression in Mar can be decreased by Mar location.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>OmpF porin expression in Mar will have decreased for Mar location.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>OmpF porin expression in Mar would be decreased by Mar location.</text>
                    <arg n="0">Mar location</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">Mar</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) may have been decreased in loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Escherichia coli can be decreased by MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Escherichia coli was able to be decreased by MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Escherichia coli was decreased in MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli can be decreased by MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) mutants of Eschrichia coli was thought to be decreased by MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar) mutants of Eschrichia coli</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>OmpF porin expression in multi-antibiotic resistant (Mar) would be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>OmpF porin expression in multibiotic resistant mutants (Mar) of Escherichia coli may have been decreased in mara place.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>OmpF porin expression is capable of being decreased by loco marA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>OmpF porin expression is decreased by loco marA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>OmpF porin expression may have been decreased by loco marA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>OmpF porin expression was considered to be decreased by loco marA, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>OmpF porin expression was shown to decreased for loco marA that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>OmpF porin has been shown to be decreased by Loco de MarA, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>OmpF porin is able to be decreased by Loco de MarA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>OmpF porin is decreased by Loco de Abraça that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>OmpF porin is decreased by Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>OmpF porin is decreased by Loco de MarA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>OmpF porin may have been decreased by Loco de MarA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>OmpF porin was shown to decreased for MarA site that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar) can be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar) could be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar) is shown to be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar) was decreased in loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>RNAM content can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">RNAM content</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>The A0 decreased the nitric induction of teor methionine, although it did not suppress the induction of nitrates, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">teor methionine</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>The A0 decreased the production of microcins C51 while it did not suppress the induction of nitrate, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="1">production of microcins C51</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>The Druption of narL showed that it decreases the digit induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>The Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli was decreased by marA place.</text>
                    <arg n="0">marA place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>The Loco de Abraça will have decreased the OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>The Loco de MarA showed that it decreases the OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>The MarA locus will have decreased the OmpF pore expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>The MarA locus will have decreased the or OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>The MarA site showed that it decreases the OmpF porin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>The Melatonin treatment is thought to decrease the lipodyl peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>The NirB promoter nitrite induction has been decreased by narL drive which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>The NirB promoter nitrite induction is thought to be decreased by the narc removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>The NirB promoter nitrite induction was decreased in the narL drive, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>The NirB promoter nitrite induction will be decreased by the narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>The NirB promoter nitrite induction will be decreased by the narc removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>The NirB promoter nitrite induction would be decreased by the narL drive that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>The NirB propulsion nitrite induction has been decreased by narcotic induction which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>The NirB propulsion nitrite induction would be decreased by narcotic induction, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>The OmpF pore expression was decreased in the MarA locus, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>The OmpF porin could be decreased by the Loco de MarA that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>The OmpF porin expression has been decreased by Loco de MarA which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>The OmpF porin expression has been decreased by loco marA which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>The OmpF porin expression in multi-antibiotic resistant (Mar) has been decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>The OmpF porin expression may have been decreased by loco marA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>The OmpF porin expression was decreased in the MarA site, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>The OmpF porin is thought to be decreased by the Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>The OmpF porin was able to be decreased by MarA site, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>The OmpF porin was decreased by Loco de MarA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>The OmpF porin was decreased in the MarA site, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>The OmpF porin will be decreased by Loco de Abraça, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>The Purina OmpF expression in Many of Scherichia coli resistant to multiple antibiotics (Mar) has been decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>The Tractally with melatonin showed that it decreases the lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>The Tractally with melatonin will have decreased the lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>The arcA expression will have decreased the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that excess of ArcA significantly decreased the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that loco marA significantly decreased OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that narc removal significantly decreased NirB promoter nitrite induction.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that narcotic removal significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that the excessive expression of Arca significantly decreased the glucose consumption.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that the expression of ArcAs overexpression significantly decreased the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that Druption of narL significantly decreased digit induction of the nirB promoter.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that Loco de Abraça significantly decreased OmpF porin.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that Loco de MarA significantly decreased OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that MarA site significantly decreased OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that excess of ArcA significantly decreased the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that nail blackout significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that narL drive significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that narL-disruption significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that over Arca expression significantly decreased glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that rupture of narL significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that Loco de MarA significantly decreased OmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that Loco de MarA significantly decreased opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that Tractally with melatonin significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that excessive arcA expression significantly decreased the consumption of glucose.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that loco marA significantly decreased opmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that narL withdrawal significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and NirB promoter nitrite induction is able to be significantly decreased to narc removal to make it significant.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and NirB propulsion nitrite induction was able to be significantly decreased in narcotic induction will be significantly greater.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and OmpF porin expression is able to be significantly decreased to MarA site to make it significant.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and OmpF porin is able to be significantly decreased to MarA site to make it significant.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and digit induction of the nirB promoter is able to be significantly decreased to Druption of narL to make it significant.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and glucose intake was able to be significantly decreased in over Arca expression will be significantly greater.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that Loco de MarA significantly decreases opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that MarA site significantly decreases OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that arcA expression significantly decreases the consumption of glucose.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that excessive arc expression significantly decreases glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that expression of ArcA overexpression significantly decreases glucose exposure.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that loco marA significantly decreases expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narL discontinuation significantly decreases nirB promoter nitric induction.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narL drive significantly decreases nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narL-disruption significantly decreases nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narL-disruption significantly decreases nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narcophagus interruption significantly decreases nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that narcotic induction significantly decreases NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that over Arca expression significantly decreases glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and lipid peroxide synthesis is able to be significantly decreased to melatonin treatment to make it significant.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and lipodyl peroxide synthesis was able to be significantly decreased in melatonin treatment will be significantly greater.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nirB nitrite promoter induction was able to be significantly decreased in natron activation will be significantly greater.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nirB promoter nitrite induction is able to be significantly decreased to rupture of narL to make it significant.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nirB promoter nitrite induction was able to be significantly decreased in narL withdrawal will be significantly greater.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitric induction promoter of nirB is able to be significantly decreased to narcophagus interruption to make it significant.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitric nirB promoter induction is able to be significantly decreased to narcophagus aborted to make it significant.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitrite induction from the nirB promoter is able to be significantly decreased to narL-disruption to make it significant.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitrite induction from the nirB promoter is able to be significantly decreased to narcotic removal to make it significant.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitrite induction of the nirB promoter was able to be significantly decreased in nail blackout will be significantly greater.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and nitrite induction of the nirB promoter was able to be significantly decreased in narcotic removal will be significantly greater.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and or OmpF porin expression was able to be significantly decreased in MarA locus will be significantly greater.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and or OmpF porin was able to be significantly decreased in Loco de MarA will be significantly greater.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and porin expression OmpF was able to be significantly decreased in loco marA will be significantly greater.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and the consumption of glucose is able to be significantly decreased to excess of ArcA expression to make it significant.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and Melatonin treatment is shown to decreased significantly lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and OmpF porin expression is significantly decreased to loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and digit induction of the nirB promoter is significantly decreased to Druption of narL.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and glucose exposure is significantly decreased to expression of ArcA overexpression.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and loco marA is shown to decreased significantly expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and narL breakdown is shown to decreased significantly nirB promoter nirB induction.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and nitrite induction of the nirB promoter is significantly decreased to narL drive.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and nitrogen nitrite induction of nitrite promoters is significantly decreased to natron activation.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and or OmpF porin is significantly decreased to Loco de MarA.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and over Arca expression is shown to decreased significantly glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and over expression of ArcA is shown to decreased significantly glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and overarch expression is shown to decreased significantly glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and whether its mutation is shown to decreased significantly promoter activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Druption of narL could significantly decrease digit induction of the nirB promoter.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA can significantly decrease opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA is shown to significantly decrease opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA is thought to significantly decrease opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA is thought to significantly decrease opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA was able to significantly decrease opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA would significantly decrease opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA locus can significantly decrease OmpF pore expression.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA locus is thought to significantly decrease or OmpF porin expression.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA site is shown to significantly decrease OmpF porin expression.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA site would significantly decrease OmpF porin expression.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Melatonin treatment can significantly decrease lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Melatonin treatment is shown to significantly decrease lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Melatonin treatment will significantly decrease lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction can be significantly decreased by narc removal significantly.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction is capable of being significantly decreased for narc removal to make it significantly.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction is thought to have been significantly decreased by narc removal to do so significantly.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB propulsion nitrite induction could be significantly decreased by narcotic induction significantly.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF pore expression may have been significantly decreased by MarA locus in a significant manner.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin can be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin expression could be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin expression was able to be significantly decreased for loco marA to do so significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin expression would be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin is thought to have been significantly decreased by MarA site to do so significantly.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin may have been significantly decreased by Loco de MarA in a significant manner.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin would be significantly decreased by Loco de Abraça significantly.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractally with melatonin is thought to significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractally with melatonin was able to significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Treaty with melatonin can significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Treaty with melatonin would significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression is thought to significantly decrease the consumption of glucose.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression will significantly decrease glucose consumption.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and digit induction of the nirB promoter may have been decreased significantly for Druption of narL significantly.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and digit induction of the nirB promoter may have been significantly decreased by Druption of narL in a significant manner.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excess ArcA is shown to significantly decrease glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excess ArcA was able to significantly decrease glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excess of ArcA expression was able to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excess of ArcA is shown to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excess of ArcA is thought to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA expression is thought to significantly decrease glucose intake.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA is shown to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA is thought to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA would significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive arc expression can significantly decrease glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive arcA expression would significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive expression of arcA could significantly decrease glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive expression of arcA is thought to significantly decrease glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and exposing excessive arcA can significantly decrease glucose intake.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and expression of ArcA overexpression could significantly decrease glucose exposure.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and expression of ArcA overexpression would significantly decrease glucose exposure.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption can be significantly decreased for arcA expression to do so significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption is capable of being significantly decreased for arcA expression to make it significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption is thought to be significantly decreased by arcA expression significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption was able to be significantly decreased for arcA expression to do so significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose exposure can be significantly decreased for expression of ArcA overexpression to do so significantly.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose exposure could be significantly decreased by expression of ArcA overexpression significantly.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose exposure may have been significantly decreased by expression of ArcA overexpression in a significant manner.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose exposure was able to be significantly decreased for expression of ArcA overexpression to do so significantly.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased by excess ArcA significantly.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased by excessive expression ArcA significantly.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased for excessive arcA expression to do so significantly.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake could be significantly decreased by excessive Ark expression significantly.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake could be significantly decreased by over Arca expression significantly.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is capable of being significantly decreased for exposing excessive arcA to make it significantly.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is shown to be significantly decreased for excessive ArcA expression significantly.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is shown to be significantly decreased for excessive expression ArcA significantly.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is shown to be significantly decreased for overexpression of ArcA significantly.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is thought to be significantly decreased by excessive expression ArcA significantly.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is thought to have been significantly decreased by excessive expression of arcA to do so significantly.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been decreased significantly for excess ArcA significantly.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been decreased significantly for excessive ArcA expression significantly.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been decreased significantly for excessive expression of arcA significantly.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been significantly decreased by excessive ArcA expression in a significant manner.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been significantly decreased by over expression of ArcA in a significant manner.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake was able to be significantly decreased for excessive expression of arcA to do so significantly.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake was able to be significantly decreased for over expression of ArcA to do so significantly.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake would be significantly decreased by excessive Ark expression significantly.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake would be significantly decreased by excessive expression of arcA significantly.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake would be significantly decreased by overarch expression significantly.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and hair peroxide synthesis is capable of being significantly decreased for melatonin treatment to make it significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and hair peroxide synthesis may have been significantly decreased by melatonin treatment in a significant manner.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and hair peroxide synthesis was able to be significantly decreased for melatonin treatment to do so significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that Loco de MarA significantly decreases opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that Loco de MarA significantly decreases or OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that Treaty with melatonin significantly decreases lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that excess ArcA significantly decreases glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that excessive ArcA significantly decreases the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that expression of ArcA overexpression significantly decreases glucose exposure.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that loco marA significantly decreases OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that narL drive significantly decreases nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that narL-disruption significantly decreases nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that narc removal significantly decreases NirB promoter nitrite induction.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that narcophagus interruption significantly decreases nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that overarch expression significantly decreases glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that whether its mutation significantly decreases promoter activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that Loco de MarA significantly decreases opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that excess of ArcA significantly decreases the consumption of glucose.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that excessive arc expression significantly decreases glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that excessive expression of arcA significantly decreases glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that loco marA significantly decreases OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that melatonin treatment significantly decreases lipid peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that narcophagus aborted significantly decreases nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that narcotic removal significantly decreases nitrite induction of the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that over expression of ArcA significantly decreases glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that treatment with melatonin significantly decreases lipid peroxide synthesis.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that NirB promoter nitrite induction was significantly decreased for narL drive significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that OmpF porin expression was significantly decreased for Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that OmpF porin was significantly decreased for Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that Tractally with melatonin significantly decreases lipid peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that excess ArcA significantly decreases glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that excessive ArcA expression significantly decreases glucose intake.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that excessive arcA expression significantly decreases glucose intake.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that glucose intake was significantly decreased for excess ArcA significantly.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that glucose intake was significantly decreased for excessive Ark expression significantly.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that loco marA significantly decreases porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that narL breakdown significantly decreases nirB promoter nirB induction.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that narL discontinuation significantly decreases nirB promoter nitric induction.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that narL drive significantly decreases NirB promoter nitrite induction.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that narcophagus interruption significantly decreases nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that narthida withdrawal significantly decreases nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that natron activation significantly decreases nitrite induction of nickel nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that nirB nitrite promoter induction was significantly decreased for natron activation significantly.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that opmpF porin expression was significantly decreased for loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that or OmpF porin expression was significantly decreased for MarA locus significantly.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that perhaps OmpF porin expression was significantly decreased for loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis could be significantly decreased by Tractally with melatonin significantly.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis is shown to be significantly decreased for Tractally with melatonin significantly.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis is shown to be significantly decreased for treatment with melatonin significantly.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis is thought to have been significantly decreased by treatment with melatonin to do so significantly.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis may have been decreased significantly for melatonin treatment significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis may have been decreased significantly for treatment with melatonin significantly.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis may have been significantly decreased by Treaty with melatonin in a significant manner.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis was able to be significantly decreased for melatonin treatment to do so significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipody peroxide synthesis can be significantly decreased for melatonin treatment to do so significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipodyl peroxide synthesis may have been decreased significantly for melatonin treatment significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA could significantly decrease expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA is thought to significantly decrease perhaps OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA is thought to significantly decrease porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA was able to significantly decrease expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA was able to significantly decrease opmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA will significantly decrease or OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA would significantly decrease or OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and locus marA can significantly decrease porin expression OmpF.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and locus marA could significantly decrease porin expression OmpF.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and melatonin treatment could significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and melatonin treatment is thought to significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and melatonin treatment was able to significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nail blackout can significantly decrease nitrite induction of the nirB promoter.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL breakdown is thought to significantly decrease nirB promoter nirB induction.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL discontinuation will significantly decrease nirB promoter nitric induction.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive is shown to significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive was able to significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL withdrawal could significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL withdrawal is shown to significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL withdrawal would significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL-disruption can significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narL-disruption could significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narc removal can significantly decrease NirB promoter nitrite induction.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus aborted is thought to significantly decrease nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus interruption could significantly decrease nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus interruption decreases significantly nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus interruption will significantly decrease nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus interruption would significantly decrease nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic induction decreases significantly NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic induction was able to significantly decrease NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic removal will significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic removal would significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and narthida withdrawal is thought to significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation could significantly decrease nirB nitrite promoter induction.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation is shown to significantly decrease nitrogen nitrite induction of nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation was able to significantly decrease nirB nitrite promoter induction.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB nitrite promoter induction can be significantly decreased for natron activation to do so significantly.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nirB induction can be significantly decreased for narL breakdown to do so significantly.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nirB induction is capable of being significantly decreased for narL breakdown to make it significantly.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nirB induction may have been significantly decreased by narL breakdown in a significant manner.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction is capable of being significantly decreased for narL drive to make it significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction is shown to be significantly decreased for rupture of narL significantly.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction is thought to be significantly decreased by narL withdrawal significantly.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction is thought to be significantly decreased by rupture of narL significantly.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction would be significantly decreased by narL drive significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitric induction promoter of nirB may have been significantly decreased by narcophagus interruption in a significant manner.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitric nirB promoter induction was able to be significantly decreased for narcophagus interruption to do so significantly.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter can be significantly decreased for narL drive to do so significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter is capable of being significantly decreased for narL-disruption to make it significantly.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter is capable of being significantly decreased for narcotic removal to make it significantly.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter is thought to be significantly decreased by narL drive significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter is thought to have been significantly decreased by narcotic removal to do so significantly.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter may have been decreased significantly for narL-disruption significantly.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter may have been decreased significantly for narcotic removal significantly.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter may have been significantly decreased by narL drive in a significant manner.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter would be significantly decreased by narL-disruption significantly.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter would be significantly decreased by narcotic withdrawal significantly.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of nickel nitrite promoters can be significantly decreased by natron activation significantly.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is capable of being significantly decreased for nail blackout to make it significantly.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is capable of being significantly decreased for narcotic removal to make it significantly.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is shown to be significantly decreased for Druption of narL significantly.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is shown to be significantly decreased for nail blackout significantly.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is shown to be significantly decreased for narL-disruption significantly.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is thought to be significantly decreased by narL drive significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter is thought to have been significantly decreased by Druption of narL to do so significantly.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter would be significantly decreased by Druption of narL significantly.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter would be significantly decreased by nail blackout significantly.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter would be significantly decreased by narL-disruption significantly.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrogen nitrite induction of nitrite promoters can be significantly decreased by natron activation significantly.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrogen nitrite induction of nitrite promoters may have been decreased significantly for natron activation significantly.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrogen nitrite induction of nitrite promoters may have been significantly decreased by natron activation in a significant manner.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and opmpF porin expression may have been significantly decreased by Loco de MarA in a significant manner.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and opmpF porin expression was able to be significantly decreased for loco marA to do so significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and opmpF porin expression would be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin can be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin can be significantly decreased for Loco de MarA to do so significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin expression could be significantly decreased by loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin expression may have been decreased significantly for MarA locus significantly.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin expression may have been decreased significantly for loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin expression may have been significantly decreased by MarA locus in a significant manner.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin expression may have been significantly decreased by loco marA in a significant manner.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and or OmpF porin would be significantly decreased by Loco de MarA significantly.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over Arca expression could significantly decrease glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over Arca expression would significantly decrease glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over expression of ArcA was able to significantly decrease glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and overarch expression could significantly decrease glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and overarch expression decreases significantly glucose intake.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and perhaps OmpF porin expression can be significantly decreased by loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF can be significantly decreased for locus marA to do so significantly.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF could be significantly decreased by loco marA significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF is thought to have been significantly decreased by loco marA to do so significantly.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and promoter activity was able to be significantly decreased for whether its mutation to do so significantly.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose can be significantly decreased for excess of ArcA expression to do so significantly.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose could be significantly decreased by the expression of ArcAs overexpression significantly.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose is shown to be significantly decreased for excess of ArcA significantly.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose is thought to be significantly decreased by excess of ArcA significantly.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose is thought to be significantly decreased by excessive ArcA significantly.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose is thought to have been significantly decreased by excess of ArcA to do so significantly.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose is thought to have been significantly decreased by the expression of ArcAs overexpression to do so significantly.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose may have been significantly decreased by excess of ArcA in a significant manner.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose may have been significantly decreased by excessive arcA expression in a significant manner.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose was able to be significantly decreased for excess of ArcA to do so significantly.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose was able to be significantly decreased for excessive ArcA to do so significantly.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose was able to be significantly decreased for excessive arcA expression to do so significantly.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose would be significantly decreased by arcA expression significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose would be significantly decreased by excessive arcA expression significantly.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of ArcA could significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of ArcA is thought to significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of Arca decreases significantly the glucose consumption.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of Arca is thought to significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the expression of ArcAs overexpression can significantly decrease the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the expression of ArcAs overexpression could significantly decrease the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the expression of ArcAs overexpression decreases significantly the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption can be significantly decreased for the excessive expression of ArcA to do so significantly.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and treatment with melatonin decreases significantly lipid peroxide synthesis.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and Melatonin treatment has significantly decreased lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and excess ArcA has significantly decreased glucose intake.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and excessive arc expression has significantly decreased glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and excessive arcA expression has significantly decreased the consumption of glucose.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and loco marA has significantly decreased OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and narL breakdown has significantly decreased nirB promoter nirB induction.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and narL discontinuation has significantly decreased nirB promoter nitric induction.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and narL-disruption has significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and narcophagus interruption has significantly decreased nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and narthida withdrawal has significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and natron activation has significantly decreased nitrogen nitrite induction of nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and over Arca expression has significantly decreased glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and overexpression of ArcA has significantly decreased glucose intake.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and the expression of ArcAs overexpression has significantly decreased the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and treatment with melatonin has significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>The digit induction of the nirB promoter may have been decreased by Druption of narL which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>The digit induction of the nirB promoter was decreased by Druption of narL, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and Druption of narL will significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and Loco de Abraça will significantly decreased OmpF porin.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and Loco de MarA decreased significantly OmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and Loco de MarA will significantly decreased OmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and MarA site decreased significantly OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction was significantly decreased by narL drive will be significantly smaller.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and NirB propulsion nitrite induction decreased significantly in narcotic induction will be significant.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and arcA expression decreased significantly glucose consumption.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and excess of ArcA expression decreased significantly the consumption of glucose.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and excessive arcA expression will significantly decreased glucose intake.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipid peroxide synthesis decreased significantly in Treaty with melatonin will be significant.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipid peroxide synthesis was significantly decreased by Treaty with melatonin will be significantly smaller.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipody peroxide synthesis was significantly decreased by melatonin treatment will be significantly smaller.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and loco marA decreased significantly expression of porin OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and loco marA decreased significantly porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and locus marA decreased significantly porin expression OmpF.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and narL-disruption will significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and narcophagus interruption decreased significantly nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and narcotic induction will significantly decreased NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and narcotic removal decreased significantly nitrite induction of the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and narthida withdrawal decreased significantly nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction decreased significantly in narL drive will be significant.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction decreased significantly in rupture of narL will be significant.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitric induction promoter of nirB was significantly decreased by narcophagus interruption will be significantly smaller.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitric nirB promoter induction was significantly decreased by narcophagus aborted will be significantly smaller.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter was significantly decreased by narL-disruption will be significantly smaller.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter was significantly decreased by narcotic withdrawal will be significantly smaller.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter decreased significantly in Druption of narL will be significant.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter decreased significantly in nail blackout will be significant.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter decreased significantly in narL drive will be significant.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter was significantly decreased by nail blackout will be significantly smaller.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and nitrogen nitrite induction of nitrite promoters decreased significantly in natron activation will be significant.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and or OmpF porin decreased significantly in Loco de MarA will be significant.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and or OmpF porin expression decreased significantly in loco marA will be significant.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and over expression of ArcA decreased significantly glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and rupture of narL decreased significantly nirB promoter nitrite induction.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and the consumption of glucose decreased significantly in excessive arcA expression will be significant.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and the glucose consumption decreased significantly in the excessive expression of Arca will be significant.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and treatment with melatonin decreased significantly lipid peroxide synthesis.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA decreases significantly the opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA will significantly decrease the opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA would significantly decrease the OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA would significantly decrease the opmpF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Loco de MarA would significantly decrease the or OmpF porin.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA locus can significantly decrease OmpF pore expression.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA locus will significantly decrease the or OmpF porin expression.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA site was able to significantly decrease OmpF porin expression.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and MarA site would significantly decrease the OmpF porin expression.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction decreased significantly for narc removal will be significantly smaller.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF pore expression decreased significantly for MarA locus will be significantly smaller.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">OmpF pore expression</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin expression decreased significantly for MarA site will be significantly smaller.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin will have been significantly decreased in Loco de MarA.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractally with melatonin will significantly decrease the lipid peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Treaty with melatonin can significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Treaty with melatonin decreases significantly the lipid peroxide synthesis.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression will significantly decrease the glucose consumption.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and arcA expression will significantly decrease the the consumption of glucose.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excess of ArcA expression will significantly decrease the the consumption of glucose.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive ArcA was able to significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive Ark expression can significantly decrease glucose intake.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive Ark expression decreases significantly the glucose intake.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive Ark expression will significantly decrease the glucose intake.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive arc expression will significantly decrease the glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive arcA expression can significantly decrease the consumption of glucose.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and excessive expression of arcA decreases significantly the glucose intake.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and expression of ArcA overexpression decreases significantly the glucose exposure.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption will have been significantly decreased in arcA expression.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake decreased significantly for excess ArcA will be significantly smaller.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake will have been significantly decreased in excess ArcA.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake will have been significantly decreased in overarch expression.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that Melatonin treatment significantly decreases lipodyl peroxide synthesis.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that excessive arc expression significantly decreases glucose intake.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that exposing excessive arcA significantly decreases glucose intake.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that loco marA significantly decreases perhaps OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that loco marA significantly decreases porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that narcotic induction significantly decreases NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that the excessive expression of ArcA significantly decreases the glucose consumption.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that the expression of ArcAs overexpression significantly decreases the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis will have been significantly decreased in Treaty with melatonin.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis will have been significantly decreased in melatonin treatment.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipodyl peroxide synthesis decreased significantly for Melatonin treatment will be significantly smaller.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipodyl peroxide synthesis decreased significantly for melatonin treatment will be significantly smaller.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipodyl peroxide synthesis will have been significantly decreased in Melatonin treatment.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA decreases significantly the opmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA was able to significantly decrease OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA was able to significantly decrease porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA will significantly decrease the porin expression OmpF.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and loco marA would significantly decrease the OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and melatonin treatment can significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nail blackout will significantly decrease the nitrite induction of the nirB promoter.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive can significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive was able to significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive will significantly decrease the nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narL drive would significantly decrease the nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narL-disruption was able to significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcophagus aborted would significantly decrease the nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic induction can significantly decrease NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic induction would significantly decrease the NirB propulsion nitrite induction.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic removal can significantly decrease nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic removal decreases significantly the nitrite induction of the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and narcotic removal would significantly decrease the nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation can significantly decrease nitrite induction of nickel nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation decreases significantly the nitrogen nitrite induction of nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation was able to significantly decrease nirB nitrite promoter induction.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation was able to significantly decrease nitrogen nitrite induction of nitrite promoters.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and natron activation would significantly decrease the nirB nitrite promoter induction.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter will have been significantly decreased in narL-disruption.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of nickel nitrite promoters decreased significantly for natron activation will be significantly smaller.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter decreased significantly for nail blackout will be significantly smaller.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter decreased significantly for narcotic removal will be significantly smaller.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter will have been significantly decreased in Druption of narL.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and over expression of ArcA decreases significantly the glucose intake.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and overexpression of ArcA decreases significantly the glucose intake.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF will have been significantly decreased in locus marA.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and rupture of narL can significantly decrease nirB promoter nitrite induction.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose will have been significantly decreased in excessive ArcA.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of ArcA can significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of ArcA would significantly decrease the the glucose consumption.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the expression of ArcAs overexpression was able to significantly decrease the consumption of glucose.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption decreased significantly for the excessive expression of ArcA will be significantly smaller.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and treatment with melatonin was able to significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and whether its mutation can significantly decrease promoter activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and whether its mutation was able to significantly decrease promoter activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and whether its mutation would significantly decrease the promoter activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and expression of porin OmpF may have been significantly decreased in loco marA will be significantly smaller.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and glucose consumption may have been significantly decreased in arcA expression will be significantly smaller.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and glucose intake may have been significantly decreased in excess ArcA will be significantly smaller.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and glucose intake may have been significantly decreased in excessive arc expression will be significantly smaller.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and lipid peroxide synthesis may have been significantly decreased in Tractally with melatonin will be significantly smaller.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and nitrite induction of the nirB promoter may have been significantly decreased in nail blackout will be significantly smaller.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and nitrite induction of the nirB promoter may have been significantly decreased in narL drive will be significantly smaller.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and opmpF porin expression may have been significantly decreased in loco marA will be significantly smaller.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and or OmpF porin may have been significantly decreased in Loco de MarA will be significantly smaller.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>The excess ArcA is thought to decrease the glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>The excess ArcA showed that it decreases the glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>The excess ArcA will have decreased the glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>The excess of ArcA is thought to decrease the the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>The excess of ArcA showed that it decreases the the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>The excessive ArcA expression is thought to decrease the glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>The excessive ArcA will have decreased the the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>The excessive arcA expression is thought to decrease the the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>The expression of ArcA overexpression showed that it decreases the glucose exposure without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>The expression of porin OmpF has been decreased by loco marA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>The expression of porin OmpF was decreased by loco marA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>The expression of porin OmpF was decreased in the loco marA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>The glucose consumption is thought to be decreased by the arcA expression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>The glucose exposure was decreased by expression of ArcA overexpression, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>The glucose exposure was decreased in the expression of ArcA overexpression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>The glucose exposure will be decreased by expression of ArcA overexpression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>The glucose intake could be decreased by the excessive Ark expression that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>The glucose intake could be decreased by the excessive expression ArcA that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>The glucose intake could be decreased by the over expression of ArcA that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>The glucose intake could be decreased by the overarch expression that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>The glucose intake has been decreased by excess ArcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>The glucose intake has been decreased by excessive expression ArcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>The glucose intake has been decreased by overarch expression which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>The glucose intake is thought to be decreased by the excess ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>The glucose intake is thought to be decreased by the excessive ArcA expression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>The glucose intake may have been decreased by excessive ArcA expression which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>The glucose intake may have been decreased by overexpression of ArcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>The glucose intake was able to be decreased by excessive arc expression, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>The glucose intake was able to be decreased by over expression of ArcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>The glucose intake was able to be decreased by overexpression of ArcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>The glucose intake was decreased by excessive Ark expression, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>The glucose intake was decreased by excessive arc expression, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>The glucose intake was decreased by excessive expression of arcA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>The glucose intake was decreased by exposing excessive arcA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>The glucose intake was decreased by over expression of ArcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>The glucose intake was decreased by the excessive expression ArcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>The glucose intake was decreased by the excessive expression of arcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>The glucose intake was decreased by the overexpression of ArcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>The glucose intake was decreased in the excessive expression ArcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>The glucose intake was decreased in the excessive expression of arcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>The glucose intake was decreased in the exposing excessive arcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>The glucose intake will be decreased by excess ArcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>The glucose intake will be decreased by excessive ArcA expression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>The glucose intake will be decreased by excessive expression of arcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>The glucose intake would be decreased by the excessive arcA expression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>The glucose intake would be decreased by the excessive expression ArcA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>The hair peroxide synthesis is thought to be decreased by the melatonin treatment that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>The hair peroxide synthesis was decreased by the melatonin treatment that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>The lipid peroxide synthesis has been decreased by Treaty with melatonin which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>The lipid peroxide synthesis is thought to be decreased by the treatment with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>The lipid peroxide synthesis may have been decreased by treatment with melatonin which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>The lipid peroxide synthesis was able to be decreased by Treaty with melatonin, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>The lipid peroxide synthesis was decreased by Treaty with melatonin, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>The lipid peroxide synthesis was decreased by melatonin treatment, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>The lipid peroxide synthesis was decreased in the treatment with melatonin, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>The lipid peroxide synthesis will be decreased by the Treaty with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>The lipid peroxide synthesis would be decreased by treatment with melatonin, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>The lipody peroxide synthesis is thought to be decreased by the melatonin treatment that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>The lipody peroxide synthesis was decreased by the melatonin treatment that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>The lipody peroxide synthesis was decreased in the melatonin treatment, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>The lipody peroxide synthesis would be decreased by melatonin treatment, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>The lipodyl peroxide synthesis could be decreased by the Melatonin treatment that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>The lipodyl peroxide synthesis is thought to be decreased by the Melatonin treatment that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>The lipodyl peroxide synthesis was decreased in the Melatonin treatment, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>The lipodyl peroxide synthesis was decreased in the melatonin treatment, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>The loco marA is thought to decrease the OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>The loco marA is thought to decrease the opmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>The loco marA is thought to decrease the or OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>The loco marA showed that it decreases the porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>The locus marA showed that it decreases the porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>The locus marA will have decreased the porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>The melatonin treatment showed that it decreases the lipodyl peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>The narL-disruption will have decreased the nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>The narL-disruption will have decreased the nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>The narcophagus aborted is thought to decrease the nitric nirB promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>The narcophagus interruption is thought to decrease the nitric nirB promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>The narcophagus interruption showed that it decreases the nitric nirB promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>The narcophagus interruption will have decreased the nitric nirB promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>The narcotic induction showed that it decreases the NirB propulsion nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>The narcotic removal showed that it decreases the nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>The narcotic withdrawal is thought to decrease the nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>The nirB nitrite promoter induction would be decreased by the natron activation that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>The nirB promoter nirB induction was decreased by the narL breakdown that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>The nirB promoter nitric induction was decreased by the narL discontinuation that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>The nirB promoter nitric induction will be decreased by the narL discontinuation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>The nirB promoter nitrite induction has been decreased by narthida withdrawal which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>The nirB promoter nitrite induction has been decreased by narthida withdrawal which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>The nirB promoter nitrite induction is thought to be decreased by the narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>The nirB promoter nitrite induction was decreased by narL withdrawal, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>The nirB promoter nitrite induction was decreased by rupture of narL, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>The nirB promoter nitrite induction was decreased by the narL withdrawal that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>The nirB promoter nitrite induction would be decreased by narL drive, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>The nirB promoter nitrite induction would be decreased by narthida withdrawal, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>The nitric nirB promoter induction is thought to be decreased by the narcophagus interruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>The nitric nirB promoter induction may have been decreased by narcophagus interruption which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>The nitric nirB promoter induction was decreased in the narcophagus interruption, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>The nitric nirB promoter induction will be decreased by the narcophagus aborted that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>The nitric nirB promoter induction will be decreased by the narcophagus interruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>The nitric nirB promoter induction would be decreased by narcophagus aborted, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>The nitrite induction from the nirB promoter has been decreased by narcotic removal which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>The nitrite induction from the nirB promoter may have been decreased by narL-disruption which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>The nitrite induction from the nirB promoter was decreased by narcotic removal, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>The nitrite induction from the nirB promoter was decreased in the narL-disruption, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>The nitrite induction from the nirB promoter will be decreased by the narcotic removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>The nitrite induction of nickel nitrite promoters may have been decreased by natron activation which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>The nitrite induction of nickel nitrite promoters was able to be decreased by natron activation, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>The nitrite induction of nickel nitrite promoters was decreased in the natron activation, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>The nitrite induction of nickel nitrite promoters would be decreased by natron activation, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>The nitrite induction of the nirB promoter could be decreased by the narcotic removal that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>The nitrite induction of the nirB promoter is thought to be decreased by the narL-disruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>The nitrite induction of the nirB promoter was decreased by nail blackout, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>The nitrite induction of the nirB promoter was decreased by narL-disruption, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>The nitrite induction of the nirB promoter was decreased in the narL drive, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>The nitrite induction of the nirB promoter was decreased in the narL-disruption, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>The nitrite induction of the nirB promoter will be decreased by nail blackout, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>The nitrite induction of the nirB promoter will be decreased by the nail blackout that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>The nitrite induction of the nirB promoter will be decreased by the narL-disruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>The nitrite induction of the nirB promoter will be decreased by the narcotic removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>The nitrogen nitrite induction of nitrite promoters has been decreased by natron activation which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>The nitrogen nitrite induction of nitrite promoters was decreased by natron activation, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>The nitrogen nitrite induction of nitrite promoters will be decreased by the natron activation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>The opmF porin expression has been decreased by Loco de MarA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>The opmF porin expression is thought to be decreased by the Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>The opmF porin expression would be decreased by Loco de MarA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>The opmpF porin expression has been decreased by Loco de MarA which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>The opmpF porin expression has been decreased by loco marA which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>The opmpF porin expression was able to be decreased by Loco de MarA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>The opmpF porin expression was decreased by Loco de MarA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>The opmpF porin expression was decreased by the Loco de MarA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>The opmpF porin expression will be decreased by the Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>The opmpF porin expression would be decreased by Loco de MarA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>The or OmpF porin expression could be decreased by the loco marA that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>The or OmpF porin expression will be decreased by MarA locus, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>The or OmpF porin has been decreased by Loco de MarA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>The or OmpF porin is thought to be decreased by the Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>The or OmpF porin was decreased by the Loco de MarA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>The or OmpF porin was decreased in the Loco de MarA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>The or OmpF porin would be decreased by Loco de MarA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>The overexpression of ArcA will have decreased the glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>The perhaps OmpF porin expression was decreased by loco marA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>The porin OmpF expression in multants of Escherichia coli resistant to multiple antibiotics (Mar) has been decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>The porin expression OmpF was decreased by the locus marA that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>The porin expression OmpF will be decreased by the loco marA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>The promoter activity could be decreased by the whether its mutation that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>The promoter activity in cardiomyocytes has been decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>The promoter activity is thought to be decreased by the whether its mutation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>The promoter activity would be decreased by the whether its mutation that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>The promotion activity in cardiomiocytics was decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and Loco de MarA is shown to significantly decreased opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and MarA site is shown to significantly decreased OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and OmpF porin expression is thought to decreased significantly in Loco de MarA will be significant.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and excessive expression ArcA is shown to significantly decreased glucose intake.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and glucose exposure is thought to decreased significantly in expression of ArcA overexpression will be significant.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and glucose intake is thought to decreased significantly in overexpression of ArcA will be significant.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and lipid peroxide synthesis is thought to decreased significantly in Treaty with melatonin will be significant.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and lipody peroxide synthesis is thought to decreased significantly in melatonin treatment will be significant.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and loco marA is shown to significantly decreased opmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and loco marA is shown to significantly decreased or OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and loco marA is shown to significantly decreased perhaps OmpF porin expression.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and locus marA is shown to significantly decreased porin expression OmpF.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and melatonin treatment is shown to significantly decreased hair peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and melatonin treatment is shown to significantly decreased lipodyl peroxide synthesis.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and narL drive is shown to significantly decreased NirB promoter nitrite induction.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and narcophagus interruption is shown to significantly decreased nitric induction promoter of nirB.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and narcotic removal is shown to significantly decreased nitrite induction from the nirB promoter.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and narthida withdrawal is shown to significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and nirB nitrite promoter induction is thought to decreased significantly in natron activation will be significant.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and nitrogen nitrite induction of nitrite promoters is thought to decreased significantly in natron activation will be significant.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and porin expression OmpF is thought to decreased significantly in loco marA will be significant.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and porin expression OmpF is thought to decreased significantly in locus marA will be significant.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression of ptsG, and the consumption of glucose is thought to decreased significantly in excess of ArcA expression will be significant.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction can be significantly decreased for narL drive.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction can be significantly decreased for narc removal will be significantly smaller.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and NirB promoter nitrite induction may have been significantly decreased in narc removal will be significantly smaller.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin can be significantly decreased for Loco de Abraça.</text>
                    <arg n="0">Loco de Abraça</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin can be significantly decreased for Loco de MarA will be significantly smaller.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin can be significantly decreased for MarA site.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and OmpF porin expression can be significantly decreased for MarA site.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and expression of porin OmpF can be significantly decreased for loco marA will be significantly smaller.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose consumption may have been significantly decreased in arcA expression will be significantly smaller.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased for excessive arcA expression.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased for excessive expression ArcA.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased for excessive expression of arcA will be significantly smaller.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake can be significantly decreased for over Arca expression.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been significantly decreased in excess ArcA will be significantly smaller.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been significantly decreased in excessive ArcA expression will be significantly smaller.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake may have been significantly decreased in excessive arcA expression will be significantly smaller.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis may have been significantly decreased in treatment with melatonin will be significantly smaller.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB nitrite promoter induction can be significantly decreased for natron activation will be significantly smaller.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB nitrite promoter induction can be significantly decreased for natron activation.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction can be significantly decreased for narL drive.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction can be significantly decreased for narL withdrawal.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction can be significantly decreased for narthida withdrawal will be significantly smaller.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction can be significantly decreased for narthida withdrawal.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction may have been significantly decreased in rupture of narL will be significantly smaller.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nitric nirB promoter induction can be significantly decreased for narcophagus interruption will be significantly smaller.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter can be significantly decreased for narcotic withdrawal.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter can be significantly decreased for narL drive.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and nitrogen nitrite induction of nitrite promoters may have been significantly decreased in natron activation will be significantly smaller.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and opmF porin expression can be significantly decreased for Loco de MarA will be significantly smaller.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and opmpF porin expression can be significantly decreased for Loco de MarA will be significantly smaller.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and promoter activity can be significantly decreased for whether its mutation.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose can be significantly decreased for arcA expression will be significantly smaller.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose can be significantly decreased for arcA expression.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose can be significantly decreased for excessive ArcA will be significantly smaller.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose can be significantly decreased for the expression of ArcAs overexpression.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the consumption of glucose may have been significantly decreased in excess of ArcA will be significantly smaller.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption may have been significantly decreased in the excessive expression of ArcA will be significantly smaller.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption may have been significantly decreased in the excessive expression of Arca will be significantly smaller.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and Druption of narL has significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and Loco de MarA has significantly decreased opmF porin expression.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and MarA site has significantly decreased OmpF porin.</text>
                    <arg n="0">MarA site</arg>
                    <arg n="1">OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and OmpF porin expression was significantly decreased for loco marA in a significant manner.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose consumption has been significantly decreased for arcA expression to do so significantly.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1277">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose consumption was significantly decreased for arcA expression in a significant manner.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1278">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose intake has been significantly decreased for excess ArcA to do so significantly.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1279">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose intake has been significantly decreased for overarch expression to do so significantly.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1280">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose intake has been significantly decreased for overexpression of ArcA to do so significantly.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1281">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose intake was significantly decreased for excessive arcA expression in a significant manner.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1282">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and glucose intake was significantly decreased for overexpression of ArcA in a significant manner.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1283">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and hair peroxide synthesis was significantly decreased for melatonin treatment in a significant manner.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1284">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and lipid peroxide synthesis has been significantly decreased for treatment with melatonin to do so significantly.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1285">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and lipodyl peroxide synthesis has been significantly decreased for melatonin treatment to do so significantly.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1286">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and locus marA has significantly decreased porin expression OmpF.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1287">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nail blackout has significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1288">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and narL-disruption has significantly decreased nitrite induction from the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1289">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and narL-disruption has significantly decreased nitrite induction of the nirB promoter.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1290">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and narcophagus aborted has significantly decreased nitric nirB promoter induction.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1291">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nirB promoter nitric induction was significantly decreased for narL discontinuation in a significant manner.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1292">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction has been significantly decreased for narL drive to do so significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1293">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction has been significantly decreased for narthida withdrawal to do so significantly.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1294">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction has been significantly decreased for rupture of narL to do so significantly.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1295">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nirB promoter nitrite induction was significantly decreased for narL drive in a significant manner.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1296">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nitrite induction from the nirB promoter has been significantly decreased for narL drive to do so significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1297">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter has been significantly decreased for narL drive to do so significantly.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1298">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter has been significantly decreased for narcotic removal to do so significantly.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1299">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and nitrite induction of the nirB promoter was significantly decreased for Druption of narL in a significant manner.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1300">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and or OmpF porin expression was significantly decreased for MarA locus in a significant manner.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1301">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and or OmpF porin expression was significantly decreased for loco marA in a significant manner.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1302">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and over Arca expression has significantly decreased glucose intake.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1303">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and promoter activity has been significantly decreased for whether its mutation to do so significantly.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1304">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and rupture of narL has significantly decreased nirB promoter nitrite induction.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1305">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and the consumption of glucose was significantly decreased for excessive ArcA in a significant manner.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1306">
                    <text>The the consumption of glucose could be decreased by the excess of ArcA expression that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1307">
                    <text>The the consumption of glucose is thought to be decreased by the excess of ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1308">
                    <text>The the consumption of glucose may have been decreased by excessive ArcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1309">
                    <text>The the consumption of glucose was able to be decreased by the expression of ArcAs overexpression, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1310">
                    <text>The the consumption of glucose was decreased by excessive ArcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1311">
                    <text>The the consumption of glucose was decreased by excessive ArcA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1312">
                    <text>The the consumption of glucose was decreased by excessive arcA expression, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1313">
                    <text>The the consumption of glucose was decreased by the excess of ArcA expression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1314">
                    <text>The the consumption of glucose was decreased in the excess of ArcA expression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1315">
                    <text>The the consumption of glucose was decreased in the excess of ArcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1316">
                    <text>The the consumption of glucose will be decreased by the expression of ArcAs overexpression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1317">
                    <text>The the consumption of glucose would be decreased by arcA expression, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1318">
                    <text>The the consumption of glucose would be decreased by the arcA expression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1319">
                    <text>The the consumption of glucose would be decreased by the the expression of ArcAs overexpression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1320">
                    <text>The the excessive expression of ArcA is thought to decrease the the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1321">
                    <text>The the excessive expression of ArcA showed that it decreases the the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1322">
                    <text>The the excessive expression of Arca showed that it decreases the the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1323">
                    <text>The the expression of ArcAs overexpression will have decreased the the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1324">
                    <text>The the glucose consumption could be decreased by the the excessive expression of ArcA that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1325">
                    <text>The the glucose consumption could be decreased by the the excessive expression of Arca that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1326">
                    <text>The the glucose consumption has been decreased by the excessive expression of ArcA which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1327">
                    <text>The the glucose consumption has been decreased by the excessive expression of Arca which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1328">
                    <text>The the glucose consumption may have been decreased by the excessive expression of ArcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1329">
                    <text>The the glucose consumption may have been decreased by the excessive expression of Arca which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1330">
                    <text>The the glucose consumption was decreased by the excessive expression of Arca, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1331">
                    <text>The the glucose consumption was decreased in the the excessive expression of ArcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1332">
                    <text>The the glucose consumption would be decreased by the excessive expression of ArcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1333">
                    <text>The the glucose consumption would be decreased by the the excessive expression of Arca that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1334">
                    <text>The treatment with melatonin is thought to decrease the lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1335">
                    <text>The whether its mutation will have decreased the promoter activity without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1336">
                    <text>Tractally with melatonin decreased lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1337">
                    <text>Tractally with melatonin has been shown to decrease the expression of lipid peroxide synthesis in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1338">
                    <text>Tractally with melatonin has decreased lipid peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1339">
                    <text>Tractally with melatonin is able to decrease lipid peroxide synthesis, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1340">
                    <text>Tractally with melatonin is shown to decrease lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1341">
                    <text>Tractally with melatonin may have decreased lipid peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1342">
                    <text>Tractally with melatonin was shown to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1343">
                    <text>Treaty with melatonin can decrease lipid peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1344">
                    <text>Treaty with melatonin decreased the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1345">
                    <text>Treaty with melatonin decreases the lipid peroxide synthesis and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1346">
                    <text>Treaty with melatonin has been shown to decrease lipid peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1347">
                    <text>Treaty with melatonin is able to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1348">
                    <text>amara place decreases expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1349">
                    <text>amara place has been shown to decrease expressive expression of OmpF pores in mutants of Escherichia coli multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1350">
                    <text>arcA expression could decrease glucose consumption, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1351">
                    <text>arcA expression decreased the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1352">
                    <text>arcA expression has decreased the consumption of glucose without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1353">
                    <text>arcA expression is able to decrease glucose consumption, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1354">
                    <text>arcA expression is able to decrease glucose consumption, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1355">
                    <text>arcA expression is able to decrease the consumption of glucose in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1356">
                    <text>arcA expression is able to decrease the glucose consumption in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1357">
                    <text>arcA expression is able to decrease the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1358">
                    <text>arcA expression is thought to decrease glucose consumption and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1359">
                    <text>arcA expression is thought to decrease the consumption of glucose, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1360">
                    <text>arcA expression may decrease glucose consumption in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1361">
                    <text>arcA expression may decrease the expression of glucose consumption in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1362">
                    <text>arcA expression may decrease the expression of the consumption of glucose in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1363">
                    <text>arcA expression may have decreased glucose consumption in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1364">
                    <text>arcA expression will decrease the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1365">
                    <text>arcA expression will decreased glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1366">
                    <text>arcA expression would decrease nitrite induction glucose consumption without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1367">
                    <text>digit induction of the nirB promoter can be decreased by Druption of narL which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1368">
                    <text>digit induction of the nirB promoter has been shown to be decreased by Druption of narL, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1369">
                    <text>digit induction of the nirB promoter is able to be decreased by Druption of narL, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1370">
                    <text>digit induction of the nirB promoter is thought to be decreased in Druption of narL, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">digit induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1371">
                    <text>excess ArcA could decrease glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1372">
                    <text>excess ArcA is able to decrease glucose intake, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1373">
                    <text>excess ArcA is able to decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1374">
                    <text>excess ArcA is thought to decrease glucose intake and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1375">
                    <text>excess ArcA may have decreased glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1376">
                    <text>excess ArcA will decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1377">
                    <text>excess of ArcA can decrease the consumption of glucose, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1378">
                    <text>excess of ArcA could decrease the consumption of glucose, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1379">
                    <text>excess of ArcA decreased the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1380">
                    <text>excess of ArcA decreases the expression of the consumption of glucose in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1381">
                    <text>excess of ArcA expression decreased the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1382">
                    <text>excess of ArcA expression decreases the the consumption of glucose and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1383">
                    <text>excess of ArcA expression is able to decrease the consumption of glucose in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1384">
                    <text>excess of ArcA expression is believed to decrease the consumption of glucose in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1385">
                    <text>excess of ArcA expression is shown to decrease the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1386">
                    <text>excess of ArcA expression was able to decrease the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1387">
                    <text>excess of ArcA expression would decrease nitrite induction the consumption of glucose without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1388">
                    <text>excess of ArcA expression would decrease the consumption of glucose, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1389">
                    <text>excess of ArcA is able to decrease the consumption of glucose, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1390">
                    <text>excess of ArcA is able to decrease the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1391">
                    <text>excess of ArcA may have decreased the consumption of glucose, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1392">
                    <text>excess of ArcA was thought to decrease the consumption of glucose, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1393">
                    <text>excess of ArcA will decreased the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1394">
                    <text>excess of ArcA would decrease the consumption of glucose, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1395">
                    <text>excess of ArcA would have decreased the the consumption of glucose in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1396">
                    <text>excessive ArcA could decrease the consumption of glucose, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1397">
                    <text>excessive ArcA decreased the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1398">
                    <text>excessive ArcA decreases the the consumption of glucose and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1399">
                    <text>excessive ArcA expression decreases the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1400">
                    <text>excessive ArcA expression is able to decrease glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1401">
                    <text>excessive ArcA expression is able to decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1402">
                    <text>excessive ArcA expression is thought to decrease glucose intake, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1403">
                    <text>excessive ArcA expression is thought to decrease the expression of glucose intake in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1404">
                    <text>excessive ArcA expression may decrease the expression of glucose intake in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1405">
                    <text>excessive ArcA expression may have decreased glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1406">
                    <text>excessive ArcA has the ability to decrease the expression of the consumption of glucose in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1407">
                    <text>excessive ArcA is able to decrease the consumption of glucose, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1408">
                    <text>excessive ArcA is shown to decrease the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1409">
                    <text>excessive ArcA may decrease the nitric induction of the consumption of glucose, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1410">
                    <text>excessive ArcA may have decreased the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1411">
                    <text>excessive ArcA may have decreased the consumption of glucose, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1412">
                    <text>excessive ArcA will decreased the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1413">
                    <text>excessive ArcA would have decreased the the consumption of glucose in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1414">
                    <text>excessive Ark expression can decrease glucose intake, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1415">
                    <text>excessive Ark expression could decrease glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1416">
                    <text>excessive Ark expression is believed to decrease glucose intake in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1417">
                    <text>excessive Ark expression is thought to decrease glucose intake and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1418">
                    <text>excessive Ark expression may decrease the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1419">
                    <text>excessive Ark expression may have decreased glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1420">
                    <text>excessive Ark expression was able to decrease the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1421">
                    <text>excessive Ark expression will decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1422">
                    <text>excessive Ark expression would decrease glucose intake, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1423">
                    <text>excessive Ark expression would decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1424">
                    <text>excessive arc expression could decrease nitric induction glucose intake while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1425">
                    <text>excessive arc expression may decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1426">
                    <text>excessive arc expression may decrease the nitric induction of glucose intake, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1427">
                    <text>excessive arc expression may have decreased glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1428">
                    <text>excessive arc expression was thought to decrease glucose intake, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1429">
                    <text>excessive arc expression would decrease glucose intake, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1430">
                    <text>excessive arcA expression has been shown to decrease the consumption of glucose, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1431">
                    <text>excessive arcA expression has been shown to decrease the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1432">
                    <text>excessive arcA expression has been shown to decrease the expression of the consumption of glucose in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1433">
                    <text>excessive arcA expression has the ability to decrease the expression of glucose intake in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1434">
                    <text>excessive arcA expression is able to decrease the consumption of glucose in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1435">
                    <text>excessive arcA expression is thought to decrease glucose intake and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1436">
                    <text>excessive arcA expression may decrease the nitric induction of the consumption of glucose, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1437">
                    <text>excessive arcA expression was able to decrease the consumption of glucose, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="1438">
                    <text>excessive arcA expression was able to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1439">
                    <text>excessive arcA expression was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1440">
                    <text>excessive expression ArcA could decrease glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1441">
                    <text>excessive expression ArcA could decrease nitric induction glucose intake while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1442">
                    <text>excessive expression ArcA decreased the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1443">
                    <text>excessive expression ArcA is able to decrease glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1444">
                    <text>excessive expression ArcA is able to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1445">
                    <text>excessive expression ArcA may decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1446">
                    <text>excessive expression ArcA may decrease the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1447">
                    <text>excessive expression ArcA may have decreased glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1448">
                    <text>excessive expression ArcA was able to decrease glucose intake, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1449">
                    <text>excessive expression ArcA was able to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1450">
                    <text>excessive expression ArcA was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1451">
                    <text>excessive expression ArcA will decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1452">
                    <text>excessive expression ArcA would have decreased the glucose intake in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1453">
                    <text>excessive expression of arcA decreased the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1454">
                    <text>excessive expression of arcA has been shown to decrease the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1455">
                    <text>excessive expression of arcA is able to decrease glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1456">
                    <text>excessive expression of arcA is thought to decrease glucose intake, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1457">
                    <text>excessive expression of arcA will decrease glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1458">
                    <text>excessive expression of arcA would decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1459">
                    <text>excessive expression of arcA would have decreased the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1460">
                    <text>exposing excessive arcA decreases the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1461">
                    <text>exposing excessive arcA has the ability to decrease the expression of glucose intake in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1462">
                    <text>exposing excessive arcA is able to decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1463">
                    <text>exposing excessive arcA is able to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1464">
                    <text>exposing excessive arcA is shown to decrease glucose intake, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1465">
                    <text>exposing excessive arcA is thought to decrease glucose intake, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1466">
                    <text>exposing excessive arcA may have decreased glucose intake, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1467">
                    <text>exposing excessive arcA was able to decrease glucose intake, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1468">
                    <text>exposing excessive arcA was able to decrease glucose intake, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1469">
                    <text>exposing excessive arcA was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1470">
                    <text>exposing excessive arcA would decrease glucose intake, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1471">
                    <text>expression of ArcA overexpression has the ability to decrease glucose exposure without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1472">
                    <text>expression of ArcA overexpression is able to decrease glucose exposure, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1473">
                    <text>expression of ArcA overexpression is able to decrease the glucose exposure in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1474">
                    <text>expression of ArcA overexpression is shown to decrease glucose exposure without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1475">
                    <text>expression of ArcA overexpression may decrease glucose exposure in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1476">
                    <text>expression of ArcA overexpression may have decreased glucose exposure in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1477">
                    <text>expression of ArcA overexpression would decrease glucose exposure, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1478">
                    <text>expression of ArcA overexpression would decrease glucose exposure, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1479">
                    <text>expression of porin OmpF can be decreased by loco marA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1480">
                    <text>expression of porin OmpF has been shown to be decreased by loco marA, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1481">
                    <text>expression of porin OmpF has decreased by loco marA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1482">
                    <text>expression of porin OmpF in multants of Escherichia coli resistant to multiple antibiotics (Mar) was able to be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1483">
                    <text>expression of porin OmpF in multants of Escherichia coli resistant to multiple antibiotics (Mar) will have decreased for loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1484">
                    <text>expression of porin OmpF in resistant to multiple antibiotics (Mar) is shown to be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1485">
                    <text>expression of porin OmpF in resistant to multiple antibiotics (Mar) may have been decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1486">
                    <text>expression of porin OmpF in resistant to multiple antibiotics (Mar) was thought to be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1487">
                    <text>expression of porin OmpF in resistant to multiple antibiotics (Mar) will have decreased for loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1488">
                    <text>expression of porin OmpF is able to be decreased by loco marA, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1489">
                    <text>expression of porin OmpF is able to be decreased by loco marA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1490">
                    <text>expression of porin OmpF is capable of being decreased by loco marA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1491">
                    <text>expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli has decreased to mar place.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1492">
                    <text>expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli may have been decreased in mar place.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1493">
                    <text>expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli was able to be decreased by amara place.</text>
                    <arg n="0">amara place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1494">
                    <text>glucose consumption can be decreased by arcA expression which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1495">
                    <text>glucose consumption is able to be decreased by arcA expression, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1496">
                    <text>glucose consumption is decreased by arcA expression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="1497">
                    <text>glucose exposure can be decreased by expression of ArcA overexpression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1498">
                    <text>glucose exposure has been shown to be decreased by expression of ArcA overexpression, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1499">
                    <text>glucose exposure has decreased by expression of ArcA overexpression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1500">
                    <text>glucose exposure is thought to be decreased in expression of ArcA overexpression, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1501">
                    <text>glucose exposure may have been decreased by expression of ArcA overexpression that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">expression of ArcA overexpression</arg>
                    <arg n="1">glucose exposure</arg>
                </example>
                <example src="PERMUTATE" no="1502">
                    <text>glucose intake can be decreased by excessive ArcA expression which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1503">
                    <text>glucose intake can be decreased by excessive Ark expression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1504">
                    <text>glucose intake can be decreased by over Arca expression, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1505">
                    <text>glucose intake can be decreased by over Arca expression, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1506">
                    <text>glucose intake can be decreased by overexpression of ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1507">
                    <text>glucose intake can be decreased by overexpression of ArcA, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1508">
                    <text>glucose intake has been shown to be decreased by over Arca expression, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1509">
                    <text>glucose intake has been shown to be decreased by over expression of ArcA, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1510">
                    <text>glucose intake has decreased by excessive Ark expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1511">
                    <text>glucose intake has decreased by excessive expression ArcA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1512">
                    <text>glucose intake has decreased by exposing excessive arcA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">exposing excessive arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1513">
                    <text>glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by excess ArcA.</text>
                    <arg n="0">excess ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1514">
                    <text>glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by over Arca expression.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1515">
                    <text>glucose intake is able to be decreased by over Arca expression, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1516">
                    <text>glucose intake is capable of being decreased by excessive arc expression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1517">
                    <text>glucose intake is capable of being decreased by excessive expression ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1518">
                    <text>glucose intake is capable of being decreased by over expression of ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1519">
                    <text>glucose intake is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1520">
                    <text>glucose intake is decreased by excessive expression of arcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression of arcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1521">
                    <text>glucose intake is shown to be decreased by excessive Ark expression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1522">
                    <text>glucose intake is shown to be decreased by excessive expression ArcA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1523">
                    <text>glucose intake is thought to be decreased in excessive Ark expression, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1524">
                    <text>glucose intake is thought to be decreased in overexpression of ArcA, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1525">
                    <text>glucose intake may have been decreased by excessive arc expression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive arc expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1526">
                    <text>glucose intake may have been decreased by over Arca expression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1527">
                    <text>glucose intake may have been decreased by overexpression of ArcA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1528">
                    <text>glucose intake was considered to be decreased by excessive Ark expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1529">
                    <text>glucose intake was decreased by excessive Ark expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1530">
                    <text>glucose intake was shown to decreased for excessive Ark expression that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive Ark expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1531">
                    <text>glucose intake was shown to decreased for excessive expression ArcA that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">excessive expression ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1532">
                    <text>glucose intake was shown to decreased for overarch expression that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1533">
                    <text>hair peroxide synthesis can be decreased by melatonin treatment, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1534">
                    <text>hair peroxide synthesis can be decreased by melatonin treatment, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1535">
                    <text>hair peroxide synthesis has decreased by melatonin treatment, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1536">
                    <text>hair peroxide synthesis is able to be decreased by melatonin treatment, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1537">
                    <text>hair peroxide synthesis is thought to be decreased in melatonin treatment, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1538">
                    <text>hair peroxide synthesis may have been decreased by melatonin treatment that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1539">
                    <text>its mutation decreased the promoting activity in cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1540">
                    <text>its mutation decreases promotion activity in cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="1541">
                    <text>its mutation has been shown to decrease promotion activity in mutants of Escherichia coli cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="1542">
                    <text>its mutation has the ability to decrease the promoter activity to cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1543">
                    <text>its mutation has the ability to decrease the promotion activity to cardiomiocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="1544">
                    <text>its mutation is demonstrated by decreasing the expression of promotion activity in cardiomiocytes mutants of Escherichia coli.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="1545">
                    <text>its mutation will decrease the promoter activity in mutants of Escherichia coli cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1546">
                    <text>its mutation will decrease the promoting activity in mutants of Escherichia coli cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1547">
                    <text>its mutation would decrease the promoter activity in mutants of Escherichia coli cardiomyocytes.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1548">
                    <text>lipid peroxide synthesis can be decreased by Tractally with melatonin which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1549">
                    <text>lipid peroxide synthesis can be decreased by Tractally with melatonin, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1550">
                    <text>lipid peroxide synthesis can be decreased by treatment with melatonin which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1551">
                    <text>lipid peroxide synthesis has been shown to be decreased by Treaty with melatonin, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1552">
                    <text>lipid peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by Treaty with melatonin.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1553">
                    <text>lipid peroxide synthesis is able to be decreased by melatonin treatment, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1554">
                    <text>lipid peroxide synthesis is capable of being decreased by Tractally with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1555">
                    <text>lipid peroxide synthesis is decreased by Tractally with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1556">
                    <text>lipid peroxide synthesis is decreased by melatonin treatment that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1557">
                    <text>lipid peroxide synthesis is shown to be decreased by Treaty with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Treaty with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1558">
                    <text>lipid peroxide synthesis is shown to be decreased by treatment with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1559">
                    <text>lipid peroxide synthesis may decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1560">
                    <text>lipid peroxide synthesis may have been decreased by treatment with melatonin, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1561">
                    <text>lipid peroxide synthesis was decreased by Tractally with melatonin, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1562">
                    <text>lipody peroxide synthesis can be decreased by melatonin treatment, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1563">
                    <text>lipody peroxide synthesis has been shown to be decreased by melatonin treatment, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1564">
                    <text>lipodyl peroxide synthesis can be decreased by Melatonin treatment, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1565">
                    <text>lipodyl peroxide synthesis can be decreased by Melatonin treatment, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1566">
                    <text>lipodyl peroxide synthesis has been shown to be decreased by Melatonin treatment, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1567">
                    <text>lipodyl peroxide synthesis has decreased by Melatonin treatment, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1568">
                    <text>lipodyl peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by Melatonin treatment.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1569">
                    <text>lipodyl peroxide synthesis is able to be decreased by Melatonin treatment, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1570">
                    <text>lipodyl peroxide synthesis is capable of being decreased by melatonin treatment that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1571">
                    <text>lipodyl peroxide synthesis is thought to be decreased in Melatonin treatment, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1572">
                    <text>lipodyl peroxide synthesis is thought to be decreased in melatonin treatment, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1573">
                    <text>loco marA could decrease OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1574">
                    <text>loco marA could decrease OmpF porin expression, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1575">
                    <text>loco marA could decrease porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1576">
                    <text>loco marA decreased expression of porin OmpF in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1577">
                    <text>loco marA decreased the OmpF porin expression in multi-antibiotic resistant (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                    <arg n="2">multi-antibiotic resistant (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1578">
                    <text>loco marA decreased the expression of porin OmpF in multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1579">
                    <text>loco marA decreased the expression of porin OmpF in resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1580">
                    <text>loco marA decreases OmpF porin expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1581">
                    <text>loco marA decreases the opmpF porin expression and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1582">
                    <text>loco marA has been shown to decrease expression of porin OmpF in mutants of Escherichia coli multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1583">
                    <text>loco marA has been shown to decrease the expression of OmpF porin expression in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1584">
                    <text>loco marA has been shown to decrease the expression of porin expression OmpF in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1585">
                    <text>loco marA has decreased or OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1586">
                    <text>loco marA has decreased porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1587">
                    <text>loco marA has the ability to decrease OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1588">
                    <text>loco marA has the ability to decrease perhaps OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1589">
                    <text>loco marA has the ability to decrease the expression of perhaps OmpF porin expression in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1590">
                    <text>loco marA has the ability to decrease the expression of porin OmpF to multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1591">
                    <text>loco marA is able to decrease opmpF porin expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1592">
                    <text>loco marA is able to decrease perhaps OmpF porin expression, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1593">
                    <text>loco marA is able to decrease the expression of porin OmpF in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1594">
                    <text>loco marA is demonstrated by decreasing the expression of or OmpF porin expression in resisting with multiple antibiotics (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1595">
                    <text>loco marA is shown to decrease expression of porin OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1596">
                    <text>loco marA is shown to decrease porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1597">
                    <text>loco marA is thought to decrease the expression of porin expression OmpF in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1598">
                    <text>loco marA may decrease OmpF porin expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1599">
                    <text>loco marA may decrease Purina OmpF expression in mutants of Escherichia coli Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1600">
                    <text>loco marA may decrease nitrite induction perhaps OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1601">
                    <text>loco marA may decrease porin OmpF expression in mutants of Escherichia coli multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1602">
                    <text>loco marA may decrease the expression of OmpF porin expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1603">
                    <text>loco marA may decrease the expression of expression of porin OmpF in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1604">
                    <text>loco marA may decrease the expression of expression of porin OmpF in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1605">
                    <text>loco marA may decrease the expression of opmpF porin expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1606">
                    <text>loco marA may decrease the expression of porin expression OmpF in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1607">
                    <text>loco marA may decrease the nitric induction of perhaps OmpF porin expression, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1608">
                    <text>loco marA may have decreased perhaps OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1609">
                    <text>loco marA was able to decrease expression of porin OmpF, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1610">
                    <text>loco marA was able to decrease or OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1611">
                    <text>loco marA was able to decrease perhaps OmpF porin expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1612">
                    <text>loco marA was able to decrease perhaps OmpF porin expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1613">
                    <text>loco marA was able to decrease porin expression OmpF, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1614">
                    <text>loco marA was thought to decrease or OmpF porin expression, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1615">
                    <text>loco marA will decrease OmpF porin expression, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1616">
                    <text>loco marA will decrease expression of porin OmpF in mutants of Escherichia coli multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">expression of porin OmpF</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1617">
                    <text>loco marA will decrease opmpF porin expression and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1618">
                    <text>loco marA will decrease opmpF porin expression, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1619">
                    <text>loco marA will decrease perhaps OmpF porin expression, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1620">
                    <text>loco marA will decrease perhaps OmpF porin expression, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1621">
                    <text>loco marA will decrease porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1622">
                    <text>loco marA will decrease porin expression OmpF, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1623">
                    <text>loco marA will decrease the Purina OmpF expression in mutants of Escherichia coli Many of Scherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">Purina OmpF expression</arg>
                    <arg n="2">Many of Scherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1624">
                    <text>loco marA will decrease the porin OmpF expression in mutants of Escherichia coli multants of Escherichia coli resistant to multiple antibiotics (Mar).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multants of Escherichia coli resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1625">
                    <text>loco marA would decrease nitrite induction or OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1626">
                    <text>loco marA would decrease nitrite induction perhaps OmpF porin expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1627">
                    <text>loco marA would decrease or OmpF porin expression, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1628">
                    <text>loco marA would have decreased the or OmpF porin expression in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1629">
                    <text>locus marA could decrease nitric induction porin expression OmpF while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1630">
                    <text>locus marA could decrease porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1631">
                    <text>locus marA decreases the expression of porin expression OmpF in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1632">
                    <text>locus marA is able to decrease porin expression OmpF in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1633">
                    <text>locus marA is able to decrease porin expression OmpF, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1634">
                    <text>locus marA is thought to decrease porin expression OmpF and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1635">
                    <text>locus marA may decrease nitrite induction porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1636">
                    <text>locus marA may have decreased porin expression OmpF, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1637">
                    <text>locus marA will decrease porin expression OmpF without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1638">
                    <text>locus marA would have decreased the expression of porin expression OmpF in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1639">
                    <text>mRNA reLN content can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="PERMUTATE" no="1640">
                    <text>mRNA reLN content decreased the synthesis of lipodyl peroxide and allowed the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="PERMUTATE" no="1641">
                    <text>mRNA reLN content may decrease the synthesis of lipid peroxide, and allows a reduced recovery of glutathione and scaveners activity.</text>
                    <arg n="0">mRNA reLN content</arg>
                </example>
                <example src="PERMUTATE" no="1642">
                    <text>mar place decreased expressive expression of OmpF pores in multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1643">
                    <text>mar place has the ability to decrease the expressive expression of OmpF pores to multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mar place</arg>
                    <arg n="1">expressive expression of OmpF pores</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1644">
                    <text>mara place decreases Expressive porin expression OmpF in multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1645">
                    <text>mara place will decrease Expressive porin expression OmpF in mutants of Escherichia coli multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1646">
                    <text>mara place would decrease the Expressive porin expression OmpF in mutants of Escherichia coli multi-antibiotic resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">mara place</arg>
                    <arg n="1">Expressive porin expression OmpF</arg>
                    <arg n="2">multi-antibiotic resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1647">
                    <text>melatonin treatment can decrease hair peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1648">
                    <text>melatonin treatment could decrease nitric induction hair peroxide synthesis while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1649">
                    <text>melatonin treatment could decrease nitric induction lipid peroxide synthesis while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1650">
                    <text>melatonin treatment decreases the expression of hair peroxide synthesis in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1651">
                    <text>melatonin treatment has the ability to decrease lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1652">
                    <text>melatonin treatment is able to decrease hair peroxide synthesis, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1653">
                    <text>melatonin treatment is able to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1654">
                    <text>melatonin treatment is thought to decrease hair peroxide synthesis, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1655">
                    <text>melatonin treatment is thought to decrease lipid peroxide synthesis, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1656">
                    <text>melatonin treatment may decrease hair peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1657">
                    <text>melatonin treatment may decrease nitrite induction lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1658">
                    <text>melatonin treatment may have decreased lipody peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1659">
                    <text>melatonin treatment may have decreased the expression of lipodyl peroxide synthesis in A2 mutants (Schirichia coli resistant mutant mutant mutant mutants).</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1660">
                    <text>melatonin treatment was able to decrease lipody peroxide synthesis, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1661">
                    <text>melatonin treatment was able to decrease the expression of hair peroxide synthesis in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">hair peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1662">
                    <text>melatonin treatment was able to decrease the expression of lipody peroxide synthesis in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1663">
                    <text>melatonin treatment was able to decrease the expression of lipodyl peroxide synthesis in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1664">
                    <text>melatonin treatment was able to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1665">
                    <text>melatonin treatment was able to decrease the lipodyl peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1666">
                    <text>melatonin treatment was shown to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1667">
                    <text>melatonin treatment will decrease lipodyl peroxide synthesis and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1668">
                    <text>melatonin treatment will decreased lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1669">
                    <text>melatonin treatment would decrease lipid peroxide synthesis, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1670">
                    <text>melatonin treatment would decrease lipody peroxide synthesis, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1671">
                    <text>melatonin treatment would decrease nitrite induction lipodyl peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1672">
                    <text>melatonin treatment would have decreased the lipodyl peroxide synthesis in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">melatonin treatment</arg>
                    <arg n="1">lipodyl peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="1673">
                    <text>mutation decreased promoter activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1674">
                    <text>mutation decreased promoter activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1675">
                    <text>mutation decreased promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1676">
                    <text>mutation decreased the promoter activity in cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1677">
                    <text>mutation decreased the promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1678">
                    <text>mutation decreases promoting activity in coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1679">
                    <text>mutation decreases promotion activity in cardiomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1680">
                    <text>mutation is demonstrated by decreasing the expression of promoter activity in cardiomycocytes mutants of Escherichia coli.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1681">
                    <text>mutation may decrease promoting activity in mutants of Escherichia coli cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="1682">
                    <text>mutation may decrease promotion activity in mutants of Escherichia coli cardiomiocytics.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="1683">
                    <text>mutation will decrease the promoting activity in mutants of Escherichia coli coriomyocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1684">
                    <text>mutation will decrease the promotion activity in mutants of Escherichia coli cardiomiocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="1685">
                    <text>mutation would decrease the promoter activity in mutants of Escherichia coli cardiomycocytes.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1686">
                    <text>nail blackout could decrease nitric induction nitrite induction of the nirB promoter while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1687">
                    <text>nail blackout could decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1688">
                    <text>nail blackout is shown to decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1689">
                    <text>nail blackout may decrease the nitric induction of nitrite induction of the nirB promoter, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1690">
                    <text>nail blackout was able to decrease nitrite induction of the nirB promoter, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1691">
                    <text>nail blackout was shown to decrease the nitrite induction of the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1692">
                    <text>narL breakdown has the ability to decrease the expression of nirB promoter nirB induction in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1693">
                    <text>narL breakdown is shown to decrease nirB promoter nirB induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1694">
                    <text>narL breakdown is thought to decrease nirB promoter nirB induction and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1695">
                    <text>narL breakdown is thought to decrease the expression of nirB promoter nirB induction in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1696">
                    <text>narL breakdown may decrease the expression of nirB promoter nirB induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1697">
                    <text>narL breakdown was thought to decrease nirB promoter nirB induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1698">
                    <text>narL discontinuation can decrease nirB promoter nitric induction, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1699">
                    <text>narL discontinuation is able to decrease the nirB promoter nitric induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1700">
                    <text>narL discontinuation may have decreased nirB promoter nitric induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1701">
                    <text>narL discontinuation was able to decrease the expression of nirB promoter nitric induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1702">
                    <text>narL discontinuation was shown to decrease the nirB promoter nitric induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1703">
                    <text>narL discontinuation was thought to decrease nirB promoter nitric induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1704">
                    <text>narL discontinuation will decrease nirB promoter nitric induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1705">
                    <text>narL discontinuation would decrease nirB promoter nitric induction, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1706">
                    <text>narL drive can decrease nitrite induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1707">
                    <text>narL drive decreased the expression of nirB promoter nitrite induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1708">
                    <text>narL drive decreased the expression of nitrite induction of the nirB promoter in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1709">
                    <text>narL drive decreases the expression of NirB promoter nitrite induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1710">
                    <text>narL drive decreases the expression of nitrite induction of the nirB promoter in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1711">
                    <text>narL drive has been shown to decrease the expression of NirB promoter nitrite induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1712">
                    <text>narL drive is able to decrease NirB promoter nitrite induction, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1713">
                    <text>narL drive is able to decrease nitrite induction of the nirB promoter, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1714">
                    <text>narL drive is shown to decrease nitrite induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1715">
                    <text>narL drive may decrease nirB promoter nitrite induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1716">
                    <text>narL drive may decrease nitrite induction NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1717">
                    <text>narL drive may decrease the expression of nitrite induction from the nirB promoter in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1718">
                    <text>narL drive may have decreased nitrite induction from the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1719">
                    <text>narL drive was able to decrease the expression of NirB promoter nitrite induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1720">
                    <text>narL drive will decrease NirB promoter nitrite induction, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1721">
                    <text>narL drive will decrease nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1722">
                    <text>narL drive will decreased nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1723">
                    <text>narL drive will decreased nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1724">
                    <text>narL drive would decrease nirB promoter nitrite induction, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1725">
                    <text>narL drive would decrease nitrite induction from the nirB promoter, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1726">
                    <text>narL withdrawal decreased nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1727">
                    <text>narL withdrawal has decreased nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1728">
                    <text>narL withdrawal has the ability to decrease nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1729">
                    <text>narL withdrawal has the ability to decrease the expression of nirB promoter nitrite induction in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1730">
                    <text>narL withdrawal is able to decrease nirB promoter nitrite induction, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1731">
                    <text>narL withdrawal is shown to decrease nirB promoter nitrite induction, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1732">
                    <text>narL withdrawal is thought to decrease the expression of nirB promoter nitrite induction in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1733">
                    <text>narL withdrawal may have decreased nirB promoter nitrite induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1734">
                    <text>narL withdrawal may have decreased nirB promoter nitrite induction, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1735">
                    <text>narL withdrawal was able to decrease nirB promoter nitrite induction, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1736">
                    <text>narL withdrawal will decrease nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1737">
                    <text>narL-disruption could decrease nitrite induction from the nirB promoter, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1738">
                    <text>narL-disruption could decrease nitrite induction of the nirB promoter, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1739">
                    <text>narL-disruption has the ability to decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1740">
                    <text>narL-disruption has the ability to decrease the expression of nitrite induction of the nirB promoter in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1741">
                    <text>narL-disruption is able to decrease nitrite induction of the nirB promoter, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1742">
                    <text>narL-disruption is shown to decrease nitrite induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1743">
                    <text>narL-disruption may have decreased nitrite induction of the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1744">
                    <text>narL-disruption may have decreased nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1745">
                    <text>narL-disruption was able to decrease nitrite induction from the nirB promoter, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1746">
                    <text>narL-disruption was able to decrease the expression of nitrite induction from the nirB promoter in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1747">
                    <text>narL-disruption will decrease nitrite induction from the nirB promoter and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1748">
                    <text>narc removal is able to decrease NirB promoter nitrite induction, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1749">
                    <text>narc removal is shown to decrease NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1750">
                    <text>narc removal may decrease the nitric induction of NirB promoter nitrite induction, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1751">
                    <text>narc removal may have decreased NirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1752">
                    <text>narc removal was thought to decrease NirB promoter nitrite induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1753">
                    <text>narc removal would decrease NirB promoter nitrite induction, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narc removal</arg>
                    <arg n="1">NirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1754">
                    <text>narcophagus aborted decreased the expression of nitric nirB promoter induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1755">
                    <text>narcophagus aborted has been shown to decrease nitric nirB promoter induction, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1756">
                    <text>narcophagus aborted is able to decrease nitric nirB promoter induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1757">
                    <text>narcophagus aborted is able to decrease nitric nirB promoter induction, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1758">
                    <text>narcophagus aborted is shown to decrease nitric nirB promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1759">
                    <text>narcophagus aborted may have decreased nitric nirB promoter induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1760">
                    <text>narcophagus aborted may have decreased the expression of nitric nirB promoter induction in A2 mutants (Schirichia coli resistant mutant mutant mutant mutants).</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1761">
                    <text>narcophagus aborted was able to decrease nitric nirB promoter induction, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1762">
                    <text>narcophagus aborted was thought to decrease nitric nirB promoter induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1763">
                    <text>narcophagus interruption can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="1764">
                    <text>narcophagus interruption decreased the expression of nitric nirB promoter induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1765">
                    <text>narcophagus interruption decreased the synthesis of lipodyl peroxide and allowed the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus interruption</arg>
                </example>
                <example src="PERMUTATE" no="1766">
                    <text>narcophagus interruption decreases nitric nirB promoter induction, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1767">
                    <text>narcophagus interruption has been shown to decrease nitric induction promoter of nirB, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1768">
                    <text>narcophagus interruption has been shown to decrease nitric nirB promoter induction, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1769">
                    <text>narcophagus interruption has been shown to decrease the expression of nitric nirB promoter induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1770">
                    <text>narcophagus interruption is able to decrease nitric nirB promoter induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1771">
                    <text>narcophagus interruption is thought to decrease nitric induction promoter of nirB, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1772">
                    <text>narcophagus interruption was able to decrease nitric induction promoter of nirB without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1773">
                    <text>narcophagus interruption was thought to decrease nitric induction promoter of nirB, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1774">
                    <text>narcophagus interruption was thought to decrease nitric nirB promoter induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1775">
                    <text>narcophagus interruption will decrease nitric nirB promoter induction, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1776">
                    <text>narcophagus interruption would have decreased the expression of nitric nirB promoter induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1777">
                    <text>narcophagus interruption would have decreased the nitric induction promoter of nirB in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1778">
                    <text>narcotic induction could decrease nitric induction NirB propulsion nitrite induction while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1779">
                    <text>narcotic induction decreases the NirB propulsion nitrite induction and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1780">
                    <text>narcotic induction decreases the expression of NirB propulsion nitrite induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1781">
                    <text>narcotic induction may decrease nitrite induction NirB propulsion nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1782">
                    <text>narcotic induction may have decreased NirB propulsion nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1783">
                    <text>narcotic induction was able to decrease NirB propulsion nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1784">
                    <text>narcotic induction was thought to decrease NirB propulsion nitrite induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narcotic induction</arg>
                    <arg n="1">NirB propulsion nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1785">
                    <text>narcotic removal can decrease nitrite induction from the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1786">
                    <text>narcotic removal decreased nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1787">
                    <text>narcotic removal decreases nitrite induction of the nirB promoter, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1788">
                    <text>narcotic removal decreases the expression of nitrite induction of the nirB promoter in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1789">
                    <text>narcotic removal decreases the nitrite induction from the nirB promoter and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1790">
                    <text>narcotic removal is able to decrease nitrite induction of the nirB promoter, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1791">
                    <text>narcotic removal is able to decrease the nitrite induction from the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1792">
                    <text>narcotic removal is shown to decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1793">
                    <text>narcotic removal is thought to decrease nitrite induction of the nirB promoter, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1794">
                    <text>narcotic removal may have decreased nitrite induction from the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1795">
                    <text>narcotic removal was able to decrease the nitrite induction from the nirB promoter in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1796">
                    <text>narcotic removal will decrease nitrite induction of the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1797">
                    <text>narcotic removal would decrease nitrite induction of the nirB promoter, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1798">
                    <text>narcotic withdrawal could decrease nitric induction nitrite induction from the nirB promoter while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1799">
                    <text>narcotic withdrawal is thought to decrease nitrite induction from the nirB promoter, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1800">
                    <text>narcotic withdrawal may decrease nitrite induction from the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1801">
                    <text>narcotic withdrawal was able to decrease nitrite induction from the nirB promoter, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1802">
                    <text>narcotic withdrawal will decreased nitrite induction from the nirB promoter without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1803">
                    <text>narcotic withdrawal would have decreased the expression of nitrite induction from the nirB promoter in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1804">
                    <text>narcotic withdrawal would have decreased the nitrite induction from the nirB promoter in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1805">
                    <text>narthida withdrawal could decrease nirB promoter nitrite induction, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1806">
                    <text>narthida withdrawal decreased the nirB promoter nitrite induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1807">
                    <text>narthida withdrawal is able to decrease nirB promoter nitrite induction, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1808">
                    <text>narthida withdrawal was thought to decrease nirB promoter nitrite induction, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1809">
                    <text>narthida withdrawal will decrease nirB promoter nitrite induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1810">
                    <text>natron activation can decrease nirB nitrite promoter induction, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1811">
                    <text>natron activation decreased nitrite induction of nickel nitrite promoters without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1812">
                    <text>natron activation decreased the expression of nirB nitrite promoter induction in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1813">
                    <text>natron activation decreases nirB nitrite promoter induction, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1814">
                    <text>natron activation decreases nitrite induction of nickel nitrite promoters, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1815">
                    <text>natron activation has been shown to decrease nirB nitrite promoter induction, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1816">
                    <text>natron activation has been shown to decrease the expression of nitrite induction of nickel nitrite promoters in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1817">
                    <text>natron activation has been shown to decrease the expression of nitrogen nitrite induction of nitrite promoters in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1818">
                    <text>natron activation is able to decrease nirB nitrite promoter induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1819">
                    <text>natron activation is able to decrease nirB nitrite promoter induction, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1820">
                    <text>natron activation is able to decrease nitrite induction of nickel nitrite promoters, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1821">
                    <text>natron activation is able to decrease the nitrogen nitrite induction of nitrite promoters in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1822">
                    <text>natron activation is believed to decrease nitrogen nitrite induction of nitrite promoters in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1823">
                    <text>natron activation is shown to decrease nitrite induction of nickel nitrite promoters, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1824">
                    <text>natron activation is thought to decrease nitrite induction of nickel nitrite promoters and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1825">
                    <text>natron activation may have decreased nitrite induction of nickel nitrite promoters without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1826">
                    <text>natron activation may have decreased the expression of nitrite induction of nickel nitrite promoters in A2 mutants (Schirichia coli resistant mutant mutant mutant mutants).</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1827">
                    <text>natron activation was able to decrease nitrite induction of nickel nitrite promoters, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1828">
                    <text>natron activation was able to decrease the expression of nirB nitrite promoter induction in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1829">
                    <text>natron activation was shown to decrease the nitrogen nitrite induction of nitrite promoters in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1830">
                    <text>natron activation will decrease nirB nitrite promoter induction without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1831">
                    <text>natron activation will decrease nitrite induction of nickel nitrite promoters without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1832">
                    <text>nirB nitrite promoter induction can be decreased by natron activation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1833">
                    <text>nirB nitrite promoter induction can be decreased by natron activation, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1834">
                    <text>nirB nitrite promoter induction can be decreased by natron activation, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1835">
                    <text>nirB nitrite promoter induction has been shown to be decreased by natron activation, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1836">
                    <text>nirB nitrite promoter induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by natron activation.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1837">
                    <text>nirB nitrite promoter induction is capable of being decreased by natron activation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nirB nitrite promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1838">
                    <text>nirB promoter is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1839">
                    <text>nirB promoter nirB induction can be decreased by narL breakdown that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1840">
                    <text>nirB promoter nirB induction has been shown to be decreased by narL breakdown, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1841">
                    <text>nirB promoter nirB induction has decreased by narL breakdown, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1842">
                    <text>nirB promoter nirB induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by narL breakdown.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1843">
                    <text>nirB promoter nirB induction is capable of being decreased by narL breakdown that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1844">
                    <text>nirB promoter nirB induction is shown to be decreased by narL breakdown that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1845">
                    <text>nirB promoter nirB induction is thought to be decreased in narL breakdown, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1846">
                    <text>nirB promoter nirB induction may have been decreased by narL breakdown, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1847">
                    <text>nirB promoter nirB induction was considered to be decreased by narL breakdown, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL breakdown</arg>
                    <arg n="1">nirB promoter nirB induction</arg>
                </example>
                <example src="PERMUTATE" no="1848">
                    <text>nirB promoter nitric induction can be decreased by narL discontinuation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1849">
                    <text>nirB promoter nitric induction can be decreased by narL discontinuation which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1850">
                    <text>nirB promoter nitric induction has been shown to be decreased by narL discontinuation, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1851">
                    <text>nirB promoter nitric induction is decreased by narL discontinuation, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL discontinuation</arg>
                    <arg n="1">nirB promoter nitric induction</arg>
                </example>
                <example src="PERMUTATE" no="1852">
                    <text>nirB promoter nitrite induction can be decreased by narL drive, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1853">
                    <text>nirB promoter nitrite induction has been shown to be decreased by narL withdrawal, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1854">
                    <text>nirB promoter nitrite induction has decreased by narL drive, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1855">
                    <text>nirB promoter nitrite induction has decreased by narL withdrawal, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1856">
                    <text>nirB promoter nitrite induction is able to be decreased by rupture of narL, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1857">
                    <text>nirB promoter nitrite induction is capable of being decreased by narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1858">
                    <text>nirB promoter nitrite induction is decreased by narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1859">
                    <text>nirB promoter nitrite induction is decreased by rupture of narL that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1860">
                    <text>nirB promoter nitrite induction is decreased by rupture of narL, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1861">
                    <text>nirB promoter nitrite induction is thought to be decreased in narthida withdrawal, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1862">
                    <text>nirB promoter nitrite induction may have been decreased by narL withdrawal, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1863">
                    <text>nirB promoter nitrite induction may have been decreased by narthida withdrawal that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narthida withdrawal</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1864">
                    <text>nirB promoter nitrite induction may have been decreased by rupture of narL, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1865">
                    <text>nirB promoter was able to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1866">
                    <text>nirB-promoter nitrite induction may decrease the synthesis of lipid peroxide, and allows a reduced recovery of glutathione and scaveners activity.</text>
                    <arg n="0">nirB-promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="1867">
                    <text>nitric induction promoter of nirB has been shown to be decreased by narcophagus interruption, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1868">
                    <text>nitric induction promoter of nirB is able to be decreased by narcophagus interruption, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1869">
                    <text>nitric induction promoter of nirB may have been decreased by narcophagus interruption that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric induction promoter of nirB</arg>
                </example>
                <example src="PERMUTATE" no="1870">
                    <text>nitric nirB promoter induction can be decreased by narcophagus aborted which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1871">
                    <text>nitric nirB promoter induction can be decreased by narcophagus interruption, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1872">
                    <text>nitric nirB promoter induction in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by narcophagus aborted.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1873">
                    <text>nitric nirB promoter induction is able to be decreased by narcophagus aborted, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1874">
                    <text>nitric nirB promoter induction is able to be decreased by narcophagus interruption, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">narcophagus interruption</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1875">
                    <text>nitric nirB promoter induction was decreased by narcophagus aborted, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcophagus aborted</arg>
                    <arg n="1">nitric nirB promoter induction</arg>
                </example>
                <example src="PERMUTATE" no="1876">
                    <text>nitrite induction from the nirB promoter can be decreased by narL drive, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1877">
                    <text>nitrite induction from the nirB promoter can be decreased by narL drive, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1878">
                    <text>nitrite induction from the nirB promoter can be decreased by narL-disruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1879">
                    <text>nitrite induction from the nirB promoter can be decreased by narL-disruption, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1880">
                    <text>nitrite induction from the nirB promoter can be decreased by narcotic removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1881">
                    <text>nitrite induction from the nirB promoter can be decreased by narcotic withdrawal which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1882">
                    <text>nitrite induction from the nirB promoter can be decreased by narcotic withdrawal, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1883">
                    <text>nitrite induction from the nirB promoter has decreased by narcotic removal, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1884">
                    <text>nitrite induction from the nirB promoter has decreased by narcotic withdrawal, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1885">
                    <text>nitrite induction from the nirB promoter may have been decreased by narL-disruption, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1886">
                    <text>nitrite induction from the nirB promoter may have been decreased by narcotic removal that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1887">
                    <text>nitrite induction from the nirB promoter may have been decreased by narcotic withdrawal that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1888">
                    <text>nitrite induction from the nirB promoter was shown to decreased for narcotic withdrawal that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narcotic withdrawal</arg>
                    <arg n="1">nitrite induction from the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1889">
                    <text>nitrite induction of nickel nitrite promoters has decreased by natron activation, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1890">
                    <text>nitrite induction of nickel nitrite promoters was considered to be decreased by natron activation, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrite induction of nickel nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1891">
                    <text>nitrite induction of the nirB promoter can be decreased by narL-disruption, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1892">
                    <text>nitrite induction of the nirB promoter can be decreased by narcotic removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1893">
                    <text>nitrite induction of the nirB promoter has been shown to be decreased by Druption of narL, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1894">
                    <text>nitrite induction of the nirB promoter has been shown to be decreased by nail blackout, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1895">
                    <text>nitrite induction of the nirB promoter has been shown to be decreased by narL drive, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1896">
                    <text>nitrite induction of the nirB promoter has been shown to be decreased by narL-disruption, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1897">
                    <text>nitrite induction of the nirB promoter has decreased by narL drive, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1898">
                    <text>nitrite induction of the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by Druption of narL.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1899">
                    <text>nitrite induction of the nirB promoter in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by narL-disruption.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1900">
                    <text>nitrite induction of the nirB promoter is able to be decreased by nail blackout, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1901">
                    <text>nitrite induction of the nirB promoter is capable of being decreased by narL-disruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1902">
                    <text>nitrite induction of the nirB promoter is decreased by Druption of narL, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Druption of narL</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1903">
                    <text>nitrite induction of the nirB promoter is decreased by narL drive that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1904">
                    <text>nitrite induction of the nirB promoter is decreased by narL-disruption that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1905">
                    <text>nitrite induction of the nirB promoter is decreased by narcotic removal that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1906">
                    <text>nitrite induction of the nirB promoter is thought to be decreased in nail blackout, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1907">
                    <text>nitrite induction of the nirB promoter may have been decreased by nail blackout, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1908">
                    <text>nitrite induction of the nirB promoter may have been decreased by narL-disruption, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1909">
                    <text>nitrite induction of the nirB promoter was considered to be decreased by narcotic removal, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narcotic removal</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1910">
                    <text>nitrite induction of the nirB promoter was decreased by narL-disruption, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1911">
                    <text>nitrite induction of the nirB promoter was shown to decreased for nail blackout that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">nail blackout</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1912">
                    <text>nitrite induction of the nirB promoter was shown to decreased for narL-disruption that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">narL-disruption</arg>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="PERMUTATE" no="1913">
                    <text>nitrogen nitrite induction of nitrite promoters can be decreased by natron activation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1914">
                    <text>nitrogen nitrite induction of nitrite promoters can be decreased by natron activation, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1915">
                    <text>nitrogen nitrite induction of nitrite promoters in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by natron activation.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1916">
                    <text>nitrogen nitrite induction of nitrite promoters is decreased by natron activation that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1917">
                    <text>nitrogen nitrite induction of nitrite promoters may have been decreased by natron activation, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1918">
                    <text>nitrogen nitrite induction of nitrite promoters was shown to decreased for natron activation that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">natron activation</arg>
                    <arg n="1">nitrogen nitrite induction of nitrite promoters</arg>
                </example>
                <example src="PERMUTATE" no="1919">
                    <text>opmF porin expression is able to be decreased by Loco de MarA, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1920">
                    <text>opmF porin expression is decreased by Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1921">
                    <text>opmF porin expression may have been decreased by Loco de MarA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1922">
                    <text>opmpF porin expression can be decreased by loco marA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1923">
                    <text>opmpF porin expression can be decreased by loco marA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1924">
                    <text>opmpF porin expression has been shown to be decreased by Loco de MarA, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1925">
                    <text>opmpF porin expression is capable of being decreased by Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1926">
                    <text>opmpF porin expression may have been decreased by Loco de MarA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1927">
                    <text>opmpF porin expression was shown to decreased for loco marA that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">opmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1928">
                    <text>or OmpF porin expression can be decreased by MarA locus, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1929">
                    <text>or OmpF porin expression can be decreased by MarA locus, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1930">
                    <text>or OmpF porin expression has been shown to be decreased by MarA locus, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1931">
                    <text>or OmpF porin expression has decreased by loco marA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1932">
                    <text>or OmpF porin expression in resisting with multiple antibiotics (Mar) would be decreased by loco marA.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                    <arg n="2">resisting with multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1933">
                    <text>or OmpF porin expression is shown to be decreased by MarA locus that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1934">
                    <text>or OmpF porin expression is shown to be decreased by loco marA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1935">
                    <text>or OmpF porin expression may have been decreased by MarA locus, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1936">
                    <text>or OmpF porin expression may have been decreased by loco marA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">or OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1937">
                    <text>or OmpF porin has decreased by Loco de MarA, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1938">
                    <text>or OmpF porin is shown to be decreased by Loco de MarA that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Loco de MarA</arg>
                    <arg n="1">or OmpF porin</arg>
                </example>
                <example src="PERMUTATE" no="1939">
                    <text>over Arca expression could decrease glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1940">
                    <text>over Arca expression may decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1941">
                    <text>over Arca expression would decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over Arca expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1942">
                    <text>over expression of ArcA decreased the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1943">
                    <text>over expression of ArcA has decreased glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1944">
                    <text>over expression of ArcA is shown to decrease glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1945">
                    <text>over expression of ArcA may have decreased glucose intake, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1946">
                    <text>over expression of ArcA may have decreased the expression of glucose intake in A2 mutants (Schirichia coli resistant mutant mutant mutant mutants).</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1947">
                    <text>over expression of ArcA was able to decrease glucose intake, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1948">
                    <text>over expression of ArcA was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1949">
                    <text>over expression of ArcA would have decreased the glucose intake in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">over expression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1950">
                    <text>overarch expression could decrease nitric induction glucose intake while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1951">
                    <text>overarch expression is able to decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1952">
                    <text>overarch expression is thought to decrease glucose intake and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1953">
                    <text>overarch expression may decrease the expression of glucose intake in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1954">
                    <text>overarch expression was able to decrease glucose intake, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1955">
                    <text>overarch expression was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1956">
                    <text>overarch expression would decrease glucose intake, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">overarch expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1957">
                    <text>overexpression of ArcA can decrease glucose intake, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1958">
                    <text>overexpression of ArcA was shown to decrease the glucose intake in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1959">
                    <text>overexpression of ArcA would decrease glucose intake, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1960">
                    <text>overexpression of ArcA would decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1961">
                    <text>overexpression of ArcA would have decreased the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">overexpression of ArcA</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="PERMUTATE" no="1962">
                    <text>perhaps NarL can decrease the synthesis of lipodyl peroxide, and allow for the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">perhaps NarL</arg>
                </example>
                <example src="PERMUTATE" no="1963">
                    <text>perhaps NarL may decrease the synthesis of lipid peroxide, and allows a reduced recovery of glutathione and scaveners activity.</text>
                    <arg n="0">perhaps NarL</arg>
                </example>
                <example src="PERMUTATE" no="1964">
                    <text>perhaps OmpF porin expression can be decreased by loco marA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1965">
                    <text>perhaps OmpF porin expression can be decreased by loco marA, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1966">
                    <text>perhaps OmpF porin expression can be decreased by loco marA, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">perhaps OmpF porin expression</arg>
                </example>
                <example src="PERMUTATE" no="1967">
                    <text>pore expression in multi-resistant mutants (Mar) of Escherichia coli will have decreased for MarA locus.</text>
                    <arg n="0">MarA locus</arg>
                    <arg n="1">pore expression</arg>
                    <arg n="2">multi-resistant mutants (Mar) of Escherichia coli</arg>
                </example>
                <example src="PERMUTATE" no="1968">
                    <text>porin expression OmpF can be decreased by loco marA, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1969">
                    <text>porin expression OmpF has been shown to be decreased by locus marA, and allows both reduced glutathione and scavenger enzyme to recover.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1970">
                    <text>porin expression OmpF has been shown to decrease or is absent in resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1971">
                    <text>porin expression OmpF in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by locus marA.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1972">
                    <text>porin expression OmpF is able to decrease or be absent in mutant cells resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1973">
                    <text>porin expression OmpF may decrease or be absent in resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1974">
                    <text>porin expression OmpF may have been decreased by loco marA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">loco marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1975">
                    <text>porin expression OmpF may have been decreased by locus marA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1976">
                    <text>porin expression OmpF was considered to be decreased by locus marA, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">locus marA</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="PERMUTATE" no="1977">
                    <text>porin expression OmpF was shown to decrease or be absent in resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1978">
                    <text>porin expression OmpF was thought to decrease or be absent in resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1979">
                    <text>porin expression OmpF would decrease or be absent in resistant to multiple antibiotics (Mar).</text>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">resistant to multiple antibiotics (Mar)</arg>
                </example>
                <example src="PERMUTATE" no="1980">
                    <text>production of C51 microcins had the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">production of C51 microcins</arg>
                </example>
                <example src="PERMUTATE" no="1981">
                    <text>production of microcines C51 had the ability to decrease or be absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcines C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1982">
                    <text>production of microcines C51 will decrease or be absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcines C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1983">
                    <text>production of microcines C51 would decrease or be absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcines C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1984">
                    <text>production of microcins C51 has decreased or been absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcins C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1985">
                    <text>production of microcins C51 was shown to decrease or be absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcins C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1986">
                    <text>production of microcins C51 will decrease or be absent in rpoS, crp and cya.</text>
                    <arg n="1">production of microcins C51</arg>
                    <arg n="2">rpoS, crp and cya</arg>
                </example>
                <example src="PERMUTATE" no="1987">
                    <text>promoter activity can be decreased by whether its mutation, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1988">
                    <text>promoter activity in cardiomycocytes could be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1989">
                    <text>promoter activity in cardiomycocytes may have been decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1990">
                    <text>promoter activity in cardiomycocytes will have decreased for mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="1991">
                    <text>promoter activity in cardiomyocytes can be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1992">
                    <text>promoter activity in cardiomyocytes can be decreased by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1993">
                    <text>promoter activity in cardiomyocytes could be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1994">
                    <text>promoter activity in cardiomyocytes has decreased to six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1995">
                    <text>promoter activity in cardiomyocytes was able to be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1996">
                    <text>promoter activity in cardiomyocytes will have decreased for its mutation.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1997">
                    <text>promoter activity in cardiomyocytes would be decreased by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="1998">
                    <text>promoter activity is decreased by whether its mutation, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="1999">
                    <text>promoter activity was considered to be decreased by whether its mutation, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2000">
                    <text>promoter activity was shown to decreased for whether its mutation that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2001">
                    <text>promoting activity in cardiomyocytes could be decreased by its mutation.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2002">
                    <text>promoting activity in cardiomyocytes was decreased in mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2003">
                    <text>promoting activity in cardiomyocytes will have decreased for its mutation.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2004">
                    <text>promoting activity in cardiomyocytes will have decreased for mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2005">
                    <text>promoting activity in coriomyocytes was decreased in mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2006">
                    <text>promoting activity in coriomyocytes was thought to be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promoting activity</arg>
                    <arg n="2">coriomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2007">
                    <text>promotion activity in cardiomiocytes is shown to be decreased by its mutation.</text>
                    <arg n="0">its mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="2008">
                    <text>promotion activity in cardiomiocytes may have been decreased in mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="2009">
                    <text>promotion activity in cardiomiocytes was thought to be decreased by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="2010">
                    <text>promotion activity in cardiomiocytics was decreased in mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="2011">
                    <text>promotion activity in cardiomiocytics will have decreased for mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytics</arg>
                </example>
                <example src="PERMUTATE" no="2012">
                    <text>promotion activity in cardiomyocytes has decreased to mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2013">
                    <text>promotion activity in cardiomyocytes was thought to be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2014">
                    <text>promotion activity in cardiomyocytes will have decreased for mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2015">
                    <text>promotive activity in cardiomycocytes was able to be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="2016">
                    <text>promotive activity in cardiomycocytes was decreased in mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="2017">
                    <text>promotive activity in cardiomycocytes would be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomycocytes</arg>
                </example>
                <example src="PERMUTATE" no="2018">
                    <text>promotive activity in cardiomyocytes is shown to be decreased by mutation.</text>
                    <arg n="0">mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2019">
                    <text>promotive activity in cardiomyocytes was decreased in their mutation.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2020">
                    <text>rupture of narL could decrease nitric induction nirB promoter nitrite induction while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2021">
                    <text>rupture of narL may decrease the nitric induction of nirB promoter nitrite induction, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2022">
                    <text>rupture of narL was shown to decrease the nirB promoter nitrite induction in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2023">
                    <text>rupture of narL will decrease nirB promoter nitrite induction and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2024">
                    <text>rupture of narL would decrease nirB promoter nitrite induction, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2025">
                    <text>rupture of narL would decrease nirB promoter nitrite induction, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">rupture of narL</arg>
                    <arg n="1">nirB promoter nitrite induction</arg>
                </example>
                <example src="PERMUTATE" no="2026">
                    <text>six mutations decreased the promoter activity in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2027">
                    <text>six mutations decreases promoter activity in cardiomyocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promoter activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2028">
                    <text>six mutations will decrease promotion activity in mutants of Escherichia coli cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="2029">
                    <text>six mutations would decrease the promotion activity in mutants of Escherichia coli cardiomiocytes.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">promotion activity</arg>
                    <arg n="2">cardiomiocytes</arg>
                </example>
                <example src="PERMUTATE" no="2030">
                    <text>the consumption of glucose can be decreased by arcA expression which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2031">
                    <text>the consumption of glucose can be decreased by arcA expression, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2032">
                    <text>the consumption of glucose can be decreased by arcA expression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2033">
                    <text>the consumption of glucose can be decreased by excess of ArcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2034">
                    <text>the consumption of glucose can be decreased by the expression of ArcAs overexpression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2035">
                    <text>the consumption of glucose can be decreased by the expression of ArcAs overexpression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2036">
                    <text>the consumption of glucose has been shown to be decreased by the expression of ArcAs overexpression, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2037">
                    <text>the consumption of glucose has decreased by excessive arcA expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">excessive arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2038">
                    <text>the consumption of glucose has the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2039">
                    <text>the consumption of glucose is able to be decreased by excess of ArcA expression, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2040">
                    <text>the consumption of glucose is decreased by arcA expression that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2041">
                    <text>the consumption of glucose is thought to be decreased in arcA expression, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">arcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2042">
                    <text>the consumption of glucose may have been decreased by excess of ArcA expression that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2043">
                    <text>the consumption of glucose may have been decreased by excessive ArcA that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2044">
                    <text>the consumption of glucose was able to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2045">
                    <text>the consumption of glucose was considered to be decreased by excessive ArcA, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excessive ArcA</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2046">
                    <text>the consumption of glucose was decreased by excess of ArcA expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">excess of ArcA expression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2047">
                    <text>the consumption of glucose was shown to decreased for the expression of ArcAs overexpression that it did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2048">
                    <text>the excessive expression of ArcA could decrease the glucose consumption without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2049">
                    <text>the excessive expression of ArcA could decrease the glucose consumption, and allowed a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2050">
                    <text>the excessive expression of ArcA decreased the the glucose consumption in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2051">
                    <text>the excessive expression of ArcA decreases the expression of the glucose consumption in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2052">
                    <text>the excessive expression of ArcA decreases the glucose consumption, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2053">
                    <text>the excessive expression of ArcA decreases the the glucose consumption and allows the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2054">
                    <text>the excessive expression of ArcA has decreased the glucose consumption without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2055">
                    <text>the excessive expression of ArcA has the ability to decrease the expression of the glucose consumption in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2056">
                    <text>the excessive expression of ArcA is able to decrease the glucose consumption, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2057">
                    <text>the excessive expression of ArcA is shown to decrease the glucose consumption, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2058">
                    <text>the excessive expression of ArcA is thought to decrease the expression of the glucose consumption in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2059">
                    <text>the excessive expression of ArcA is thought to decrease the glucose consumption and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2060">
                    <text>the excessive expression of ArcA may decrease nitrite induction the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2061">
                    <text>the excessive expression of ArcA may decrease the expression of the glucose consumption in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2062">
                    <text>the excessive expression of ArcA may have decreased the glucose consumption in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2063">
                    <text>the excessive expression of ArcA may have decreased the glucose consumption in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2064">
                    <text>the excessive expression of ArcA was able to decrease the expression of the glucose consumption in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2065">
                    <text>the excessive expression of ArcA will decrease the glucose consumption, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2066">
                    <text>the excessive expression of ArcA would decrease the glucose consumption, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2067">
                    <text>the excessive expression of ArcA would have decreased the the glucose consumption in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2068">
                    <text>the excessive expression of Arca can decrease the glucose consumption, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2069">
                    <text>the excessive expression of Arca can decrease the glucose consumption, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2070">
                    <text>the excessive expression of Arca decreases the expression of the glucose consumption in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2071">
                    <text>the excessive expression of Arca decreases the glucose consumption, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2072">
                    <text>the excessive expression of Arca has decreased the glucose consumption without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2073">
                    <text>the excessive expression of Arca is shown to decrease the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2074">
                    <text>the excessive expression of Arca is thought to decrease the glucose consumption and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2075">
                    <text>the excessive expression of Arca may have decreased the glucose consumption, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2076">
                    <text>the excessive expression of Arca will decrease the glucose consumption and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2077">
                    <text>the excessive expression of Arca will decrease the glucose consumption, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2078">
                    <text>the excessive expression of Arca will decreased the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2079">
                    <text>the expression of ArcAs overexpression is able to decrease the consumption of glucose, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2080">
                    <text>the expression of ArcAs overexpression is able to decrease the the consumption of glucose in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2081">
                    <text>the expression of ArcAs overexpression will decreased the consumption of glucose without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the expression of ArcAs overexpression</arg>
                    <arg n="1">the consumption of glucose</arg>
                </example>
                <example src="PERMUTATE" no="2082">
                    <text>the glucose consumption can be decreased by the excessive expression of Arca, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2083">
                    <text>the glucose consumption is able to be decreased by the excessive expression of Arca, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2084">
                    <text>the glucose consumption is able to be decreased by the excessive expression of Arca, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2085">
                    <text>the glucose consumption is decreased by the excessive expression of Arca that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of Arca</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="PERMUTATE" no="2086">
                    <text>the reLN mRNA content decreased the synthesis of lipodyl peroxide and allowed the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="2087">
                    <text>the reLN mRNA content was able to decrease nirB-induced nirB-promoting nirB-induction while not suppressing nitrate-inducing, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="2088">
                    <text>the reLN mRNA content would decrease nirB-promoting nirB-induction, while it would not suppress nitrate induction, suggesting that there might be a second nitrate response factor.</text>
                    <arg n="0">the reLN mRNA content</arg>
                </example>
                <example src="PERMUTATE" no="2089">
                    <text>their mutation decreased the promotive activity in cardiomyocytes.</text>
                    <arg n="0">their mutation</arg>
                    <arg n="1">promotive activity</arg>
                    <arg n="2">cardiomyocytes</arg>
                </example>
                <example src="PERMUTATE" no="2090">
                    <text>treatment with melatonin decreased lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2091">
                    <text>treatment with melatonin decreased the expression of lipid peroxide synthesis in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2092">
                    <text>treatment with melatonin has the ability to decrease lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2093">
                    <text>treatment with melatonin has the ability to decrease the expression of lipid peroxide synthesis in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2094">
                    <text>treatment with melatonin is able to decrease the lipid peroxide synthesis in A2 mutants (multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2095">
                    <text>treatment with melatonin is shown to decrease lipid peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2096">
                    <text>treatment with melatonin is thought to decrease the expression of lipid peroxide synthesis in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2097">
                    <text>treatment with melatonin may decrease the nitric induction of lipid peroxide synthesis, while it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2098">
                    <text>treatment with melatonin was able to decrease lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2099">
                    <text>treatment with melatonin would decrease lipid peroxide synthesis, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2100">
                    <text>treatment with melatonin would decrease nitrite induction lipid peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2101">
                    <text>treatment with melatonin would have decreased the lipid peroxide synthesis in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">treatment with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="PERMUTATE" no="2102">
                    <text>whether its mutation could decrease promoter activity without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2103">
                    <text>whether its mutation decreased the expression of promoter activity in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2104">
                    <text>whether its mutation has been shown to decrease the expression of promoter activity in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2105">
                    <text>whether its mutation is able to decrease promoter activity, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2106">
                    <text>whether its mutation may decrease the expression of promoter activity in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2107">
                    <text>whether its mutation will decrease promoter activity and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2108">
                    <text>whether its mutation will decrease promoter activity, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2109">
                    <text>whether its mutation would decrease promoter activity, and allow for a recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="PERMUTATE" no="2110">
                    <text>whether its mutation would decrease promoter activity, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">whether its mutation</arg>
                    <arg n="1">promoter activity</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>A0 has decreased Clench cell secreting protein levels, and has enabled the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>A0 has decreased Clench cell secretory protein levels, and has enabled the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>A0 has decreased clean cell secretor protein levels, and has enabled the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>A0 has decreased consisting protein levels of crystalline cells, and has enabled the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="1">consisting protein levels of crystalline cells</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>A0 has the ability to decrease metonic content without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">metonic content</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>A0 has the ability to decrease the production of C51 microcin without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">the production of C51 microcin</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>A0 is able to decrease the nitric induction of clac secretor protein levels, without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">clac secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>A0 is able to decrease the nitric induction of clean cell secretor protein levels, without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>A0 is able to decrease the nitric induction of cloth cell secretor protein levels, without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>A0 is thought to decrease nitrite induction in clac secretor protein levels, although it does not suppress nitrate induction, suggesting that a second nitrate response factor may occur.</text>
                    <arg n="1">clac secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>A0 is thought to decrease nitrite induction in clean cell secretor protein levels, although it does not suppress nitrate induction, suggesting that a second nitrate response factor may occur.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>A0 is thought to decrease nitrite induction in consisting protein levels of crystalline cells, although it does not suppress nitrate induction, suggesting that a second nitrate response factor may occur.</text>
                    <arg n="1">consisting protein levels of crystalline cells</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>A0 is thought to decrease nitrite induction in metonic content, although it does not suppress nitrate induction, suggesting that a second nitrate response factor may occur.</text>
                    <arg n="1">metonic content</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and marA locus is thought to have significantly decreased porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and marA locus may have significantly decreased porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>ArchA gene suppression causes a 2-fold increase in the expression ptsG, and sea can significantly decrease Porin OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Clench cell secreting protein levels decreased or was absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Clench cell secreting protein levels has the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Crystalline cell secreting protein levels had the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Crystalline cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Crystalline cell secreting protein levels may decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Crystalline cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Crystalline cell secreting protein levels was able to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Crystalline cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Crystalline cell secretory protein levels will decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">Crystalline cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Elevation of the arcA gene caused a 2-fold increase in ptsG expression, and it was observed that marA locus significantly decreased porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and A0 is able to significantly decrease protein levels secreting crystal cells.</text>
                    <arg n="1">protein levels secreting crystal cells</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Elevation of the arcA gene causes a 2-fold increase in ptsG expression, and it has been shown that lipody peroxide synthesis was significantly decreased to Tractally with melatonin.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>If this 30 amino acid distance is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA would be severely affected and claco secretory protein levels would be decreased, or even suppressed in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">claco secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>If this 30 amino acid distance is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA would be severely affected and nitrite induction of the nirB promoter would be decreased, or even suppressed in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>If this 30 amino acid distance is not maintained, as in AspRS chimera#1, or in the yeast LysTS chimera#1 and yeast AsnRS chimera#2 (Figure 5B), binding to the tRNA would be severely affected and protein levels secreting crystal cells would be decreased, or even suppressed in the case of AspRS chimera#1 (Table).</text>
                    <arg n="1">protein levels secreting crystal cells</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, over Arca expression is able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>In brain areas of patients with schizophrenia that are homologous to those of non-psychiatric subjects, over expression of Arca is able to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">over expression of Arca</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, excessive ArcA expression may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, marA locus was able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">marA locus</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, narL drive may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">narL drive</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, over ArcA expression was able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over ArcA expression</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, over Arca expression may be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, sea is able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">sea</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the excessive expression of ArcA may be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the excessive expression of ArcA may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the excessive expression of Arca was able to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of Arca</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>In brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the excessive expression of arcA may be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>In brain decreasingas of patients with schizophrenia that decreasing homologous to those of non-psychiatric subjects, excessive ArcA expression was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>In brain decreasingas of patients with schizophrenia that decreasing homologous to those of non-psychiatric subjects, sea was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">sea</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>In brain decreasingas of patients with schizophrenia who decreasing homologous to those of non-psychiatric subjects, Tractament with melatonin was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>In brain decreasingas of patients with schizophrenia who decreasing homologous to those of non-psychiatric subjects, the excessive expression of ArcA was significantly lower (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of ArcA</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression level may have been reduced and nitrite induction of the nirB promoter may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and Clench cell secreting protein levels may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and clac secretor protein levels may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">clac secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and claco secretory protein levels may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">claco secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and cloth cell secretor protein levels may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and levels of crystalline cell secretor proteins may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">levels of crystalline cell secretor proteins</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consistent with this expression may be lower and the production of C51 microcin may be decreased), and neither RAP2 nor RAP3 are co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">the production of C51 microcin</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consisting of these expression levels may have been lower and Clench cell secreting protein levels may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitations in RAP1 mutants.</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>In contrast, only low levels of truncated RAP1 peptides are detected (consisting of these expression levels may have been lower and consisting protein levels of crystalline cells may have been decreased), and neither RAP2 nor RAP3 are co-immunoprecipitations in RAP1 mutants.</text>
                    <arg n="1">consisting protein levels of crystalline cells</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and consisting protein levels of crystalline cells could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">consisting protein levels of crystalline cells</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these levels of expression could be reduced and Clench cell secreting protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">Clench cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these levels of expression could be reduced and Clench cell secretory protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these levels of expression could be reduced and Crystalline cell secreting protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">Crystalline cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>In contrast, only low levels of truncated RAP1 peptides were detected (consisting of these levels of expression could be reduced and clean cell secretor protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipitated in RAP1 mutants.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression is able to be lowered and Crystalline cell secreting protein levels is able to be decreased), and neither RAP2 nor RAP3 is co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">Crystalline cell secreting protein levels</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression is able to be lowered and Crystalline cell secretory protein levels is able to be decreased), and neither RAP2 nor RAP3 is co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">Crystalline cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression is able to be lowered and levels of crystalline cell secretor proteins is able to be decreased), and neither RAP2 nor RAP3 is co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">levels of crystalline cell secretor proteins</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression is able to be lowered and metonic content is able to be decreased), and neither RAP2 nor RAP3 is co-immunoprecipitate in RAP1 mutants.</text>
                    <arg n="1">metonic content</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and Crystalline cell secretory protein levels may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">Crystalline cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and clench cell secretor protein levels may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">clench cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>In contrast, only the low levels of truncated RAP1 peptides are detected (consistent with this expression may have been lower and protein levels secreting crystal cells may have been decreased), and neither RAP2 nor RAP3 co-immunoprecipitate in RAP1 mutants are co-immunoprecipitate.</text>
                    <arg n="1">protein levels secreting crystal cells</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and Crystalline cell secretory protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">Crystalline cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and clac secretor protein levels could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">clac secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>In contrast, only the low levels of truncated RAP1 peptides were detected (consisting of these expression levels could be reduced and levels of crystalline cell secretor proteins could be decreased), and neither RAP2 nor RAP3 were coimmunoprecipites in RAP1 mutants.</text>
                    <arg n="1">levels of crystalline cell secretor proteins</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric individuals, it is demonstrated that Tractally with melatonin is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric individuals, it is demonstrated that narL drive is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">narL drive</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric subjects, excessive arc expression is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>In the brain areas of patients with schizophrenia homologous to those of non-psychiatric subjects, over expression of Arca may decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">over expression of Arca</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, Tractally with melatonin will be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, Tractament with melatonin would have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, excessive ArcA expression would have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, excessive arc expression is decreased a significant reduction (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, excessive arc expression will be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>In the brain areas of patients with schizophrenia who are homologous to those of non-psychiatric subjects, the excessive expression of arcA would have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>In the cerebral areas of patients of schizophrenia homologous to non-psychiatric subjects, over Arca expression can decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>In the cerebral areas of patients of schizophrenia homologous to non-psychiatric subjects, sea can decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">sea</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>In the cerebral areas of schizophrenia patients homologous to non-psychiatric subjects, Tractally with melatonin is significantly decreasing (4050%; see Table 2).</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>In the cerebral areas of schizophrenia patients homologous to non-psychiatric subjects, marA locus is significantly decreasing (4050%; see Table 2).</text>
                    <arg n="0">marA locus</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>In the cerebral areas of schizophrenia patients homologous to non-psychiatric subjects, the excessive expression of Arca is significantly decreasing (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of Arca</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, Tractally with melatonin is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, Tractament with melatonin may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, Tractament with melatonin will have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, excessive ArcA expression is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, excessive ArcA expression would be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, excessive arc expression can be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, excessive arc expression has decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, excessive arc expression is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive arc expression</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it is shown that the excessive expression of arcA is significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it was shown that excessive ArcA expression was significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it was shown that over ArcA expression was significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over ArcA expression</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, it was shown that over expression of Arca was significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over expression of Arca</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, narL drive was believed to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">narL drive</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, narL drive will have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">narL drive</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, over ArcA expression may have been significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over ArcA expression</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, over Arca expression is thought to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, over Arca expression was believed to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, sea was believed to decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">sea</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the excessive expression of Arca is thought to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of Arca</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the excessive expression of arcA has decreased significantly (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the excessive expression of arcA is thought to be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In the cerebral areas of schizophrenia patients homologous to those of non-psychiatric subjects, the excessive expression of arcA would be significantly decreased (4050%; see Table 2).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>It is believed that marA locus decreases porin OmpF expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>It was believed that marA locus decreases porin expression OmpF without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>It was believed that over expression of Arca decreases glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>It was believed that the Porin OmpF expression was decreased by sea that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>It was believed that the glucose intake was decreased by over ArcA expression that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>It was believed that the lipody peroxide synthesis was decreased by Tractally with melatonin that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>Local MEF2 binding sites have been reported in several cardiac promoters and marA locus decreases the porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>Local MEF2 binding sites have been reported in several cardiac promoters and marA locus decreases the porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and marA locus would decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>Local MEF2 binding sites have been reported in various cardiac promoters and marA locus would decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and marA locus decreases porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and marA locus would decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and marA locus would decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and marA locus would decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>Local binding sites of MEF2 have been reported in several cardiac promoters and sea decreases Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and Porin OmpF expression was decreased in sea in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus had the ability to decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus has been able to decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus has been considered to decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus has been considered to decrease porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus has the ability to decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus has the ability to decrease porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus may decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus may decrease porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus will decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and marA locus will decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and porin OmpF expression was decreased in marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and porin OmpF expression was decreased in marA locus in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and sea had the ability to decrease Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>MEF2 binding sites have been reported in several cardiac promoters and sea is able to decrease Porina OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and Porin OmpF expression is able to be decreased in sea into multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and Porin OmpF expression is believed to be decreased in sea into multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and Porina OmpF expression has been considered to be decreased by sea in multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is able to be decreased in marA locus into multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is able to be decreased in marA locus into multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is able to be decreased in marA locus into multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>MEF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is believed to be decreased in marA locus into multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and Porina OmpF expression could be decreased by sea in multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and Porina OmpF expression is decreased by sea in multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus can decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus had the ability to decrease porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus had the ability to decrease porin expression OmpF in Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus is able to decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus will decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and marA locus will decrease porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and over ArcA expression is supposed to decrease glucose intake (cardiomyocytes).</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression could be decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression has decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression has decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression has decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression is decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression is thought to be decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin OmpF expression will be decreased by marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin expression OmpF could be decreased by marA locus in Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin expression OmpF has decreased by marA locus in Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and porin expression OmpF is thought to be decreased by marA locus in Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and sea is supposed to decrease Porin OmpF expression (cardiomyocytes).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>MeF2 binding sites have been reported in several cardiac promoters and the excessive expression of arcA is supposed to decrease the glucose consumption (cardiomyocytes).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>MeF2 binding sites have been reported in several cardiac promoters, and marA locus has the ability to decrease porin expression OmpF in Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                    <arg n="2">Multi-antibiotic-resistant Escherichia coli (Mar) mutants was decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and Porin OmpF expression will be decreased by sea to multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and Porin OmpF expression would be decreased by sea to multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and marA locus may decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and marA locus may decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and marA locus may decrease porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression has been decreased by marA locus to multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is decreased in marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression is decreased in marA locus in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression was able to be decreased by marA locus into multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression would be decreased by marA locus to multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression would be decreased by marA locus to multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression would be decreased by marA locus to multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression would be decreased in marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>MeF2 binding sites have been reported in various cardiac promoters and porin OmpF expression would be decreased in marA locus in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Porin OmpF expression can be decreased by sea that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Porin OmpF expression can be decreased by sea, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Porin OmpF expression can be decreased by sea, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Porin OmpF expression has been shown to be decreased by sea, and allows both glutathione reduction and scavenger enzyme to recover.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea) may have been decreased by sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Porin OmpF expression was considered to be decreased by sea, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Porina OmpF expression is able to be decreased by sea, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Porina OmpF expression is able to be decreased by sea, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Porina OmpF expression is thought to be decreased in sea, which is not suppressed by nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Porina OmpF expression may have been decreased by sea that is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>The A0 decreased the cloth cell secretor protein levels while it did not suppress the induction of nitrate, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>The A0 decreased the metonic content while it did not suppress the induction of nitrate, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="1">metonic content</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>The A0 decreased the nitric induction of Clench cell secretory protein levels, although it did not suppress the induction of nitrates, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">Clench cell secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>The A0 decreased the nitric induction of clean cell secretor protein levels, although it did not suppress the induction of nitrates, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>The A0 decreased the nitric induction of cloth cell secretor protein levels, although it did not suppress the induction of nitrates, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>The Porin OmpF expression has been decreased by sea which has not been suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>The Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea) has been decreased by sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>The Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea) was decreased by sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>The Porin OmpF expression was decreased by sea, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>The Porin OmpF expression was decreased in the sea, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>The Porin OmpF expression would be decreased by the sea that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>The Porina OmpF expression could be decreased by the sea that was not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>The Porina OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea) has been decreased by sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>The Porina OmpF expression was decreased by the sea that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>The Porina OmpF expression was decreased in the sea, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>The Tractament with melatonin is thought to decrease the lipid peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression of ptsG, and it is observed that Tractament with melatonin significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that Tractament with melatonin significantly decreased lipid peroxide synthesis.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that marA locus significantly decreased porin expression OmpF.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that over ArcA expression significantly decreased glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it is observed that sea significantly decreased Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that marA locus significantly decreased porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>The deletion of the arcA gene caused a 2-fold increase in the expression ptsG, and it was observed that sea significantly decreased Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and it is observed that over expression of Arca significantly decreases glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>The deletion of the arcA gene causes a 2-fold increase in ptsG expression, and lipody peroxide synthesis is able to be significantly decreased to Tractally with melatonin to make it significant.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and lipid peroxide synthesis is significantly decreased to Tractament with melatonin.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and marA locus is shown to decreased significantly porin expression OmpF.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression of ptsG, and over expression of Arca is shown to decreased significantly glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and A0 is capable of significantly decreasing clean cell secretor protein levels.</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Porin OmpF expression is thought to be significantly decreased by sea significantly.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Porina OmpF expression is thought to have been significantly decreased by sea to do so significantly.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Porina OmpF expression may have been decreased significantly for sea significantly.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractally with melatonin can significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractally with melatonin would significantly decrease lipody peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractament with melatonin can significantly decrease lipid peroxide synthesis.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake could be significantly decreased by over expression of Arca significantly.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and glucose intake is shown to be significantly decreased for over expression of Arca significantly.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that Tractament with melatonin significantly decreases lipid peroxide synthesis.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that marA locus significantly decreases porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is observed that the excessive expression of arcA significantly decreases the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that marA locus significantly decreases porin expression OmpF.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that sea significantly decreases Porin OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that Tractally with melatonin significantly decreases lipody peroxide synthesis.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that porin OmpF expression was significantly decreased for marA locus significantly.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and it was shown that porin expression OmpF was significantly decreased for marA locus significantly.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis is capable of being significantly decreased for Tractament with melatonin to make it significantly.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis is shown to be significantly decreased for Tractament with melatonin significantly.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and lipody peroxide synthesis is thought to be significantly decreased by Tractally with melatonin significantly.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and marA locus decreases significantly porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and marA locus is shown to significantly decrease porin expression OmpF.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over ArcA expression can significantly decrease glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over ArcA expression is thought to significantly decrease glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over ArcA expression was able to significantly decrease glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over expression of Arca is shown to significantly decrease glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over expression of Arca was able to significantly decrease glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and over expression of Arca will significantly decrease glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF is shown to be significantly decreased for marA locus significantly.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and sea could significantly decrease Porin OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and sea could significantly decrease Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and sea decreases significantly Porin OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and sea decreases significantly Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and sea is shown to significantly decrease Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of arcA can significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of arcA decreases significantly the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption can be significantly decreased for the excessive expression of arcA to do so significantly.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption is shown to be significantly decreased for the excessive expression of arcA significantly.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>The deletion of the arcA gene causes a 2-fold increase in the expression ptsG, and the glucose consumption was able to be significantly decreased for the excessive expression of arcA to do so significantly.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>The deletion of the arcA gene has caused a 2-fold increase in the expression ptsG, and marA locus has significantly decreased porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>The discontinuation of excessive ArcA expression, although it does not decrease the induction of nitrate, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>The discontinuation of narL drive, although it does not decrease the induction of nitrate, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">narL drive</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipid peroxide synthesis decreased significantly in Tractament with melatonin will be significant.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipid peroxide synthesis was significantly decreased by Tractament with melatonin will be significantly smaller.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and lipody peroxide synthesis decreased significantly in Tractally with melatonin will be significant.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and marA locus decreased significantly porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and over expression of Arca decreased significantly glucose intake.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and sea decreased significantly Porin OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>The elevation of the arcA gene caused approximately a 2-fold increase in the expression ptsG, and the excessive expression of arcA decreased significantly the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Porin OmpF expression decreased significantly for sea will be significantly smaller.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Porin OmpF expression will have been significantly decreased in sea.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and Tractament with melatonin will significantly decrease the lipid peroxide synthesis.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that marA locus significantly decreases porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and it is thought that the excessive expression of arcA significantly decreases the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and lipid peroxide synthesis decreased significantly for Tractament with melatonin will be significantly smaller.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and marA locus can significantly decrease porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and marA locus was able to significantly decrease porin OmpF expression.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and over ArcA expression was able to significantly decrease glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and over ArcA expression will significantly decrease the glucose intake.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and porin expression OmpF will have been significantly decreased in marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and sea decreases significantly the Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and sea was able to significantly decrease Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and sea will significantly decrease the Porina OmpF expression.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of arcA can significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>The elevation of the arcA gene causes a 2-fold increase in the expression ptsG, and the excessive expression of arcA was able to significantly decrease the glucose consumption.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and glucose intake may have been significantly decreased in over expression of Arca will be significantly smaller.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and porin OmpF expression may have been significantly decreased in marA locus will be significantly smaller.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>The elevation of the arcA gene causes an increase of about 2-fold in the expression ptsG, and porin expression OmpF may have been significantly decreased in marA locus will be significantly smaller.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>The glucose intake may have been decreased by over expression of Arca which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>The lipid peroxide synthesis may have been decreased by Tractament with melatonin which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>The lipid peroxide synthesis was decreased by the Tractament with melatonin that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>The lipody peroxide synthesis may have been decreased by Tractally with melatonin which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>The lipody peroxide synthesis was decreased by Tractally with melatonin, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>The porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus) was decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>The porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus) was decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>The porin OmpF expression was decreased by the marA locus that did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>The porin expression OmpF was able to be decreased by marA locus, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>The porin expression OmpF was decreased in the marA locus, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and Porin OmpF expression may have been significantly decreased in sea will be significantly smaller.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and Porina OmpF expression can be significantly decreased for sea will be significantly smaller.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and lipody peroxide synthesis may have been significantly decreased in Tractally with melatonin will be significantly smaller.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>The removal of the arcA gene causes a 2-fold increase in the expression ptsG, and porin OmpF expression can be significantly decreased for marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>The sea will have decreased the Porin OmpF expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>The sea will have decreased the Porina OmpF expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>The suppression of the arcA gene caused a 2-fold increase in the expression ptsG, and the glucose consumption was significantly decreased for the excessive expression of arcA in a significant manner.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>The the glucose consumption may have been decreased by the excessive expression of arcA which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>The the glucose consumption was able to be decreased by the excessive expression of arcA, which did not suppress nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>The the glucose consumption was decreased by the excessive expression of arcA, which was not suppressed by nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>The the glucose consumption will be decreased by the excessive expression of arcA, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>Tractally with melatonin can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>Tractally with melatonin could decrease nitric induction lipody peroxide synthesis while not suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>Tractally with melatonin decreases lipody peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>Tractally with melatonin is shown to decrease lipody peroxide synthesis, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>Tractally with melatonin was able to decrease lipody peroxide synthesis, and allowed the recovery of reduced glutathione and scavenger activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>Tractally with melatonin was able to decrease nirB-induced nirB-promoting nirB-induction while not suppressing nitrate-inducing, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>Tractally with melatonin was thought to decrease lipody peroxide synthesis, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>Tractally with melatonin will decreased lipody peroxide synthesis without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>Tractament with melatonin could decrease lipid peroxide synthesis without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>Tractament with melatonin has the ability to decrease the expression of lipid peroxide synthesis in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>Tractament with melatonin is able to decrease lipid peroxide synthesis, and allows the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>Tractament with melatonin is thought to decrease the expression of lipid peroxide synthesis in multi-antibiotic (Mar) resistance mutants of Escherichia coli.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>Tractament with melatonin may decrease the synthesis of lipid peroxide, and allows a reduced recovery of glutathione and scaveners activity.</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>Tractament with melatonin was able to decrease lipid peroxide synthesis, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>Tractament with melatonin was thought to decrease lipid peroxide synthesis, and allowed for a recovery of both reduced glutathione and scavenger enzyme activity.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>Tractament with melatonin will decrease lipid peroxide synthesis and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>Tractament with melatonin would decrease nirB-promoting nirB-induction, while it would not suppress nitrate induction, suggesting that there might be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>claco secretory protein levels is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">claco secretory protein levels</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>clean cell secretor protein levels may decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">clean cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>clench cell secretor protein levels is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">clench cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>clench cell secretor protein levels may decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">clench cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>cloth cell secretor protein levels has the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">cloth cell secretor protein levels</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>consisting protein levels of crystalline cells was able to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">consisting protein levels of crystalline cells</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>excessive ArcA expression may decrease the synthesis of lipid peroxide, and allows a reduced recovery of glutathione and scaveners activity.</text>
                    <arg n="0">excessive ArcA expression</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>glucose intake has decreased by over ArcA expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>glucose intake is able to be decreased by over ArcA expression, and allows both reduced glutathione and scavenger enzyme to be recovered.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>glucose intake is able to be decreased by over expression of Arca, which is not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>glucose intake is capable of being decreased by over expression of Arca that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>levels of crystalline cell secretor proteins had the ability to decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">levels of crystalline cell secretor proteins</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>levels of crystalline cell secretor proteins is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">levels of crystalline cell secretor proteins</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>lipid peroxide synthesis is shown to be decreased by Tractament with melatonin that does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractament with melatonin</arg>
                    <arg n="1">lipid peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>lipody peroxide synthesis can be decreased by Tractally with melatonin, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>lipody peroxide synthesis in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli) was considered decreased by Tractally with melatonin.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>lipody peroxide synthesis is decreased by Tractally with melatonin, which does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>lipody peroxide synthesis may have been decreased by Tractally with melatonin, which is not suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">Tractally with melatonin</arg>
                    <arg n="1">lipody peroxide synthesis</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>marA locus can decrease lipid peroxide synthesis, and allows for reduced glutathione recovery and scavenger activity.</text>
                    <arg n="0">marA locus</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>marA locus can decrease porin OmpF expression, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>marA locus could decrease porin OmpF expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>marA locus decreased porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>marA locus decreased the expression of porin OmpF expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>marA locus decreased the porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>marA locus decreased the porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>marA locus decreased the porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>marA locus has been shown to decrease porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is able to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>marA locus has been shown to decrease porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>marA locus has been shown to decrease porin expression OmpF, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>marA locus has the ability to decrease the expression of porin OmpF expression in A2 mutants (Resistance to Multi-antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>marA locus is believed to decrease porin OmpF expression in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>marA locus is demonstrated by decreasing the expression of porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus) mutants of Escherichia coli.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>marA locus is demonstrated by decreasing the expression of porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus) mutants of Escherichia coli.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>marA locus is thought to decrease porin expression OmpF and allows both reduced glutathione and scavenger activity to recover.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>marA locus may decrease porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>marA locus will decrease porin OmpF expression and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>marA locus will decrease porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>marA locus will decrease porin OmpF expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>marA locus will decrease porin expression OmpF, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin expression OmpF</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>marA locus will decrease the porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>marA locus will decrease the porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>marA locus would decrease nirB-promoting nirB-induction, while it would not suppress nitrate induction, suggesting that there might be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>marA locus would decrease nitrite induction porin OmpF expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>marA locus would decrease porin OmpF expression, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>marA locus would decrease the porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>marA locus would decrease the porin OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>marA locus would have decreased the porin OmpF expression in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>nitrite induction of the nirB promoter is considered to be decreasing or absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">nitrite induction of the nirB promoter</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>over ArcA expression decreased glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>over ArcA expression has been shown to decrease glucose intake, and allows for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>over ArcA expression is believed to decrease glucose intake in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>over ArcA expression is shown to decrease glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>over ArcA expression is thought to decrease glucose intake, and allow for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>over ArcA expression was able to decrease glucose intake, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>over ArcA expression will decrease glucose intake and allow for the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>over ArcA expression would decrease nitrite induction glucose intake without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">over ArcA expression</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>over Arca expression can decrease the synthesis of lipodyl peroxide, and allow for the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over Arca expression</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>over expression of Arca can decrease the synthesis of lipodyl peroxide, and allow for the recovery of reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">over expression of Arca</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>over expression of Arca decreased glucose intake without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>over expression of Arca decreases the expression of glucose intake in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>over expression of Arca has been shown to decrease the expression of glucose intake in A2 mutants (multiresistant antibiotic (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>over expression of Arca is able to decrease glucose intake in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>over expression of Arca is believed to decrease glucose intake in A2 (multi-resistant mutants (Mar) of Escherichia coli.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>over expression of Arca is shown to decrease glucose intake, and allows for the recovery of both reduced glutathione and scavenger activity.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>over expression of Arca may have decreased glucose intake, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>over expression of Arca will decrease glucose intake, while not suppressing nitrate induction, suggesting that there may be a second nitrate-responsive factor.</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>over expression of Arca would decrease nirB-promoting nirB-induction, while it would not suppress nitrate induction, suggesting that there might be a second nitrate response factor.</text>
                    <arg n="0">over expression of Arca</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>over expression of Arca would have decreased the glucose intake in A2 mutants (multi-resistant antibiotics (Mar) of Escherichia coli).</text>
                    <arg n="0">over expression of Arca</arg>
                    <arg n="1">glucose intake</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus) can be decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus) could be decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is considered to be decreased by A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus) will have decreased for marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants is decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus) will have decreased for marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants may be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus) has decreased to marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants will be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus) may have been decreased by marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>porin OmpF expression in multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus) was decreased in marA locus.</text>
                    <arg n="0">marA locus</arg>
                    <arg n="1">porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic-resistant Escherichia coli (Mar) mutants was able to be decreased in A0 (marA locus)</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>sea can decrease Porin OmpF expression, and allows for the recovery of both reduced glutathione and scavenger enzymes.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>sea decreased Porin OmpF expression in multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants are considered to be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>sea has been shown to decrease Porina OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>sea has decreased Porina OmpF expression without suppressing nitrate induction, suggesting that there could be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>sea is able to decrease Porin OmpF expression in A2 mutants (resistant to multiple antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>sea is shown to decrease Porina OmpF expression without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>sea may decrease the expression of Porin OmpF expression in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>sea may decrease the expression of Porina OmpF expression in A2 mutants (multiresistant antibiotics (Mar) of Escherichia coli.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>sea may decrease the expression of Porina OmpF expression in multi-antibiotic (Mar) mutants of Escherichia coli.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>sea may have decreased Porina OmpF expression, although it does not suppress nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>sea was able to decrease Porin OmpF expression, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porin OmpF expression</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>sea will decrease Porina OmpF expression in mutants of Escherichia coli multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea).</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                    <arg n="2">multi-antibiotic resistant Escherichia coli (Mar) mutants can be decreased by A0 (sea)</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>sea would decrease Porina OmpF expression, and would allow for both reduced glutathione and scaveners activity to recover.</text>
                    <arg n="0">sea</arg>
                    <arg n="1">Porina OmpF expression</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>the excessive expression of arcA decreased the glucose consumption without suppressing nitrate induction, suggesting that there may be a second nitrate response factor.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>the excessive expression of arcA is able to decrease the glucose consumption, and allows the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>the excessive expression of arcA may have decreased the expression of the glucose consumption in A2 mutants (Schirichia coli resistant mutant mutant mutant mutants).</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>the glucose consumption was considered to be decreased by the excessive expression of arcA, and allowed the recovery of both reduced glutathione and scavenger enzyme.</text>
                    <arg n="0">the excessive expression of arcA</arg>
                    <arg n="1">the glucose consumption</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>the production of C51 microcin will decrease or be absent in the A2 mutant cells (rpoS, crp and cya).</text>
                    <arg n="1">the production of C51 microcin</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
